View
3
Download
0
Category
Preview:
Citation preview
HerzzentrumUniversitŠtsspital Basel
Herzzentrum
HerzzentrumJahresbericht 2017
02
Mehr wissen. Alles geben.Mehr machen. Besser kšnnen.Zusammen arbeiten. Mehr erreichen.
03
Vorwort
Liebe Kolleginnen und Kollegen, liebe Leserinnen und Leser
In Zeiten eines immer schnelleren Umbruchs stehen wir im Herzzentrum des Univer-sitŠtsspitals Basel fŸr BestŠndigkeit und QualitŠt in Therapie, Innovation und Forschung. Gerade in der Behandlung von Herzerkrankungen eršffnen sich faszinierende und neue Therapiemšglichkeiten zum Nutzen unserer Patienten und Patientinnen. Parallel dazu steigen aber auch der permanente Druck auf Kosten und Prozessoptimierun-gen. Somit spielt auch der betriebswirtschaftliche Aspekt eine immer bedeutendere Rolle. In diesem Spannungsfeld arbeiten alle Teams des Herzzentrums tagtŠglich fŸr die kontinuierliche Verbesserung von BehandlungsqualitŠt und Serviceleistung.
Alle Spitzenleistungen unseres Herzzentrums sind nur durch die enge Verzahnung mit Ihnen als HausŠrzt(inn)en und niedergelassenen Kardiolog(inn)en mšglich. Der enge fachliche und persšnliche Austausch mit Ihnen bildet dabei die Basis fŸr die BehandlungskontinuitŠt und den Langzeiterfolg.
Herzlichen Dank fŸr Ihren offenen Dialog und konstruktives Feedback sowie fŸr die sehr gute Zusammenarbeit.
Friedrich Eckstein Christian MŸller Stefan Osswald
04
Inhalt
01 Dienstleistungen 06 - 13
Leistungsstatistik UniversitŠtsspital Kardiologie / Herzchirurgie / PartnerspitŠler Outcomestatistik 02 Kardiologie 14 - 25
Interventionelle Kardiologie Elektrophysiologie Echokardiographie Cardiac Imaging Herzinsuffizienz KardiovaskulŠre PrŠvention / GUCH KARAMBA (Kardiale Rehabilitation) Kurzzeitklinik / Pflege / MTT / MTRA Administration / Controlling Outcome Forschung Swiss-AF Cohort Study Grundlagenforschung 03 Herzchirurgie 26 - 29
04 Notfallzentrum 30 - 31
05 Medizinische Intensivstation 32 - 33
06 KardioanŠsthesie 34 - 35 07 Operative Intensivbehandlung (OIB) 36 - 37
08 Lehre 38 - 39
09 Finanzielles 40 - 43 10 Publikationen Kardiologie / Herzchirurgie 44 - 55
Originalarbeiten / Reviews / Editorials / Letters to the editor Case reports / Books & Book chapters
11 Auszeichnungen 56 - 57
12 Kontakt 58
05
StationŠre Patienten
Kardiologische Ambulatorien
Schrittmacherkontrollen
ICD-Kontrollen
Rhythmussprechstunde
Kardiologische AbklŠrungen
Herzinsuffizienz-Sprechstunde
LVAD-Kontrollen
GUCH-Sprechstunde
Privatsprechstunden
Hypertonie Sprechstunde
Rauchstopp Sprechstunde
Konsile
Spezialuntersuchungen
Linksherzkatheter
Rechtsherzkatheter
Myokard-Biopsie
Elektrophysiologische Untersuchungen
Echokardiographien, transthorakal
Echokardiographien, transoesophageal
Stressechokardiographien
24 h Blutdruckmessungen
Somnotouch
Herz-MR
Herz-CT
Ergometrien (inkl. Nuklearmedizin)
Spiroergometrien
Myokardperfusionsszintigraphien
Herz-PET
2017
2'191
1'712
1'582
481
1'463
587
86
140
1'451
1'277
968
2'520
2'481
156
15
82
11'691
1'118
236
1'275
471
994
586
2'301
120
977
685
2015
2'050
1'644
1'514
398
881
547
n.a.
122
1008
813
541
1'459
2'525
175
23
80
9'275
979
145
1004
137
715
232
1'248
72
1'618
n.a.
Leistungsstatistik Kardiologie UniversitŠtsspital
Dienstleistungen
01 Dienstleistungen
06
2014
1'872
1'704
1'757
403
678
460
n.a.
123
846
730
497
2'002
2'354
179
25
53
8'854
891
123
846
n.a.
627
277
1'195
83
1'571
n.a.
2016
2'200
1'691
1'649
452
1'049
547
45
130
1'304
1'001
758
1'602
2'473
155
27
71
10'810
1'051
220
1'224
296
738
356
2'074
84
1'466
55
Elektrokardiographie
Ruhe-EKG 1
Langzeit-EKG Untersuchungen inkl. R-Tests
Therapie
Kardioversionen
Schrittmacherimplantationen
Schrittmacherwechsel / Schrittmacherrevision
Elektrodenentfernungen
ICD-Implantationen
ICD-Wechsel / ICD-Revision
CRT-ICD / CRT-PM
Implantierbare Loop Recorder
Ablationen
PTCA
Mehrast-PTCA
Sinus Coronarius Reduktion
Aortenvalvuloplastien
Verschluss eines ASD / PFO
Nicht operativer Aortenklappenersatz (TAVI)
- davon transfemoral
- davon transapikal
MitraClip
Indirekte Mitralklappenanuloplastie
Direkte Mitralklappenanuloplastie
Renale Denervationen
Vorhofsohrverschluss
Mitralklappenvalvuloplastien
ParavalvulŠrer Leckverschluss
TASH
Rehabilitation (KARAMBA)
2017
13'786
1'776
245
287
63
17
85
51
55
49
741
1'336
385
3
3
41
131
120
11
12
1
1
4
21
2
1
1
411
Leistungsstatistik Kardiologie UniversitŠtsspital
07
2014
12'127
631
165
273
61
19
87
52
53
n.a.
581
1'193
364
n.a.
2
47
107
77
30
18
n.a.
n.a.
n.a.
7
4
n.a.
2
363
2015
11'473
1'842
208
283
77
15
125
47
57
n.a.
646
1'279
422
n.a.
1
27
103
85
18
13
n.a.
n.a.
1
11
5
n.a.
1
389
2016
15'082
1'783
228
304
73
29
88
54
53
50
710
1'278
387
6
1
33
131
112
19
15
4
n.a.
1
9
n.a.
2
n.a.
331
Bruderholzspital
Ruhe-EKG Langzeit-EKG (24-h) R-Tests Ergometrien Echokardiographie, transthorakal Echokardiographie, transoesophageal Stressechokardiographie Myokardperfusionsszintigraphie (in Zusammenar. m. Radiol.) MRI (in Zusammenarbeit mit Radiologie) BD-Messung (24-h) Schrittmacherkontrollen inkl. ICD Schrittmacherimplantationen inkl. -wechsel Kardioversionen StationŠre Konsilien
Service de Cardiologie Hopital du Jura
ErgometrienEchokardiographie, transthorakalEchokardiographie, transoesophagealMRIEKGR-TestSchrittmacherimplantationenElektrodenentfernungen/Repositionierung Loop recorder Implantation Loop recorder KontrolleSchrittmacherkontrollenICD-KontrollenHolter 24 h Blutdruckmessungen
2017
10'922748
32338
1'6946422865783
6734940
726
2624
3054
3522
2810
12
17719
1945
Leistungsstatistik PartnerspitŠler
Dienstleistungen
01 Dienstleistungen
08
2014
10'936553
34329
1'9179323
1277182
8287242
867
174673
1379
8259
2414
n.a.n.a.340
29n.a.n.a.
2015
11'539633
38340
1'9488325
11978
118828
6744
735
136537
484
424123117
n.a.n.a.374
36n.a.n.a.
2016
10'385547
54454
1'9427222
1237058
7266250
782
n.a.378
829
27254
11n.a.n.a.171
9139n.a.
Leistungsstatistik Herzchirurgie UniversitŠtsspital
Prozeduren
Operationen mit Herz-Lungen-Maschine (HLM)
Operationen ohne Herz-Lungen-Maschine (HLM)
Sonstige Operationen (Schrittmacher, ICD, Perikard, etc.)
Kombinationseingriffe (Herzoperationen mit HLM)
Bypasschirurgie
Aortokoronarer Bypass (AKB) isoliert mit HLM
Aortokoronarer Bypass (AKB) ohne HLM ("OPCAB")
Kombinationseingriffe (AKB+)
Aortenklappenchirurgie
Aortenklappenersatz biologisch
Aortenklappenersatz mechanisch
Aortenklappenrekonstruktion mit Eigenperikard (OP nach Ozaki)
Aortenklappen- und Wurzelersatz ("Composite")
Aortenklappenrekonstruktion
Transapikaler Aortenklappenersatz (ohne HLM, mit Kardiol.)
Mitralklappenchirurgie
Mitralklappenersatz mit HLM
Mitralklappenrekonstruktion mit HLM
Rekonstruktionsrate (geplant vs. durchgefŸhrt)
Andere
Trikuspidal- und Pulmonalklappenchirurgie
Trikuspidalklappenrekonstruktion
Pulmonalklappenersatz
2017
1061
535
99
233
229
319
165
20
134
225
107
28
10
30
29
16
121
32 (26/6)
85 (42/43)
97%
4
26
24
2
09
2014
1'157
631
112
210
210
417
234
50
132
273
167
39
n.a.
35
36
31
117
31
85
n.a.
n.a.
15
14
1
2015
1031
568
101
195
195
345
208
29
110
208
119
34
8
23
25
18
133
43(40/3)
87 (43/44)
97%
3
16
16
0
2016
1098
533
121
196
198
313
168
27
116
234
127
35
15
13
24
19
121
46 (43/3)
73 (33/40)
98%
2
12
11
1
Operationen an der thorakalen Aorta
Sonstige Eingriffe
Vorhofablation/Pulmonalvenenisolation
Vorhofseptumdefekt
Extrakorporale Zirkulation (EKZ)
Minimalisierte EKZ ("MECC")
Hypothermer Kreislaufstillstand
Kardiale UnterstŸtzungssysteme
Intraaortale Ballonpulsation (IABP)
Extrakorporale Membranoxygenation (ECMO)
LVAD (Destinationstherapie)
Eingriffsdringlichkeit
Elektiv
Notfall
Dringlich
Konsile Kardiologie
2017
105
51
15
36
535
145
90
51
21
22
8
577
122
77
308
2015
87
50
16
34
568
196
71
61
42
19
2
504
135
141
269
Leistungsstatistik Herzchirurgie UniversitŠtsspital
Dienstleistungen
01 Dienstleistungen
10
2014
104
53
21
32
631
232
79
53
31
22
n.a.
530
89
80
n.a.
2016
82
48
10
38
533
146
74
49
28
21
3
567
154
129
285
11
Outcome Statistik
Die medizinische QualitŠt ist zentraler Fokus bei den von der Kardiologie des USB angebotenen Leistungen. Gerade in Zeiten einer rasanten Entwicklung vor allem in technischen Bereichen der Medizin ist die exakte und lŸckenlose Aufarbei-tung von Komplikationen und TodesfŠllen, welche im Spital auftreten (In-hospital Mortality) von enormer Wichtigkeit. Im Rahmen der QualitŠtskontrolle der Abteilung Kardiologie erfolgt eine systematische Erfassung aller Eingriffe, welche im Laufe eines Jahres durchgefŸhrt werden. Basierend auf interdisziplinŠren Besprechungen im Rahmen von sogenannten Morbidity&Mortality Konferenzen (M&M) wird dabei nicht nur die In-hospital Mortality sondern auch die Procedure-related Mortality ermittelt. Beides sind wichtige Messgršssen in der QualitŠtskontrolle, welche die Kardiologie des USB seit mehre-ren Jahren transparent rapportiert.In der untenstehenden Tabelle sind alle TodesfŠlle aufgelistet, die nach einer kardiologischen Intervention aufgetreten sind. Hierzu ist anzumerken, dass dabei auch TodesfŠlle rapportiert werden, welche nicht kausal mit der Intervention zusammen-hŠngen. Deshalb wird zusŠtzlich auch die procedure-related Mortality rapportiert.
Anzahl
Untersuchungen
1'336
1'145
151
741
350
136
55
17
156
15
62
In-hospital Tod
N (%)
42 (3.1%)
33 (2.9%)
4 (2.6%)
0
2 (0.6%)
0
0
1 (5.9%)
1 (0.6%)
0
1 (1.6%)
Procedure-related Tod
N (%)
3 (0.2%)
1 (0.1%)
3 (2.0%)
0
0
0
0
0
0
0
0
Untersuchungstyp
PTCA / Stentimplantationen
Linksherzkatheter (ohne PTCA)
Interventionelle Klappeneingriffe *
Katheterablationen
Schrittmacher-Implantationen
Schrittmacher-Wechsel/-revision
ICD-Implantationen
ICD-Wechsel/-revision
CRT-ICD / CRT-PM
Elektrodenextraktion
Rechtsherzkatheter
Biopsie
ASD/PFO-Verschluss
* TAVI (n=131, davon 117 transfemoral), Valvuloplastien der Aortenklappe oder Mitralklappe (AVP: n=3, MVP: n=2), Mitraclip (n=12), indirekte Mitralklappenannuloplastie (n=1), direkte Mitralklappenannuloplastie (n=1), Verschluss paravalvulŠres Leck (n=1)
12 13
Dienstleistungen
01 Dienstleistungen
Interventionelle Kardiologie
Team
�rztliches Team
Prof. Christoph KaiserProf. Raban JegerDr. Gregor Fahrni
Wissenschaftliches Team
Dr. Nicole GilgenAndrea Harder-AllgšwerFranziska JordanMargarete Baumgartner
02 Kardiologie
14
Elektrophysiologie
Team
�rztliches Team
Prof. Christian SticherlingProf. Stefan OsswaldPD Dr. Michael KŸhnePD Dr. Tobias ReichlinProf. Beat SchŠr
Technisches Team
Dr. Sven KnechtFlorian Spiess
Team Schrittmacher/ICD Sprechstunde
Christine HuldiAndrea Mussler
Wissenschaftliches Team
Sarah GiesebartGian Všllmin
15
Echokardiographie
Team
�rztliche Mitarbeiter Echokardiographie
Prof. Beat KaufmannProf. Michael ZellwegerPD Dr. Otmar PfisterPD Dr. Daniel ToblerDr. Thilo BurkardDr. Marc Fischer Dr. Philipp HaafDr. Arnheid KesselDr. Wanda KloosDr. Jens LohrmannProf. Christine Meyer-ZŸrnDr. Karsten MurrayDr. Frank-Peter Stephan
Mitarbeiter Cardiovascular Molecular Imaging
Prof. Beat KaufmannDr. Amanda Ochoa-EspinosaDr. Mukesh PunjabiDr. Lifen XuDr. David Steinl Alexandra Kosareva
02 Kardiologie
16
Cardiac Imaging
Team
Prof. Michael ZellwegerDr. Thilo BurkardDr. Philip HaafDr. Patrick BadertscherKollaboration mit Radiologie und Nuklearmedizin
1717
Herzinsuffizienz
02 Kardiologie
18
Dr. Ina FerelBrigitte FitzeRomy MayrStephanie DšrflingerKristin ShresthaClaudia Stelzig
Team
�rztliches Team
PD Dr. Otmar PfisterProf. Christian MŸllerProf. Martin GrapowProf. Peter RickenbacherPD Dr. Gabriela Kuster PfisterProf. Michael ZellwegerDr. Jens LohrmannDr. Thilo Burkard
VAD-Koordination
Simon ScheifeleMarcel Henz
Herzinsuffizienzberatung / Studien
Lukas Weibel (ANP)Salom� RŸmmlerDr. Beate HartmannDayana FloresDr. Samyut ShresthaJonas Schwarz
19
KardiovaskulŠre PrŠvention / GUCH
Team KardiovaskulŠre PrŠvention / Hypertonie � Standort USB-MedPol
Dr. Thilo BurkardDr. Andrea MeienbergDr. Corinna KlŸberDr. Annina VischerDr. Elena Lardi, AA (1.7. bis 31.12.17)Dr. Maria-Luisa de Perna, AA (ab 1.7.17)Dr. Marc HŠfliger, AA (1.1. bis 31.3.17)Dr. Rupprecht Lange (1.4. bis 30.6.17)Dr. Pietro Lardelli (ab 1.10.17)Dr. Delphine Glinz-MagnenatDr. Leo Killian
Team GUCH / Angeborene Herzfehler
PD Dr. Daniel ToblerKetina ArslaniProf. Birgit DonnerLukas NotzNico RofflerGaby Frey
Rauchstopp-Beraterinnen:Uta EnglerNathalie Klaus
Blutdruckassistentinnen:Valerie JunghaenelOlivia ZahnSimone Erne
KARAMBA (Kardiale Rehabilitation)
02 Kardiologie
20
Team
�rzte
PD Dr. Otmar PfisterDr. Thilo BurkardDr. Karsten MurrayDr. Marc FischerDr. Manuela Florence BernoulliDr. Cornelia GanzoniDr. Rupprecht LangeDr. Roger Moser (Psychosomatik)
Pflege/Administration
Antonia CandelaGaby FreySarah Rigling
Sporttherapie
Madeleine Wick (Leitung)Julia LŠderachStephanie RuchFabienne SchneiderRuth Ostertag
Livia GrafTheresia KohlerAndrea Iris Bannwart
Physiotherapie
Yolanda Sanchez (Leitung)Kevin VogelPatrick ProbstNatali Marjanovic
Aquagymnastik
Monika RšthlisbergerTanja Biedermann
Herzinsuffizienzberatung
Lukas Weibel (ANP)Salom� RŸmmler
Kurzzeitklinik/Pflege/MTRA
Team KUK (Station 8.2)
Susanne TimusCatherine MalgatProf. Christian MŸllerDr. Wanda KloosDr. Jens Lohrmann
Team Pflege / MTT
Rosemarie BŸhrerDr. Sven Knecht Sšren LorenzClaudia LutzPaul BlindStephan Griessbach (ab 02.01.17) Jšrg Hassler (ab 01.04.17 temporŠr)Constance Deininger (bis 31.12.17)Brigitte Wiedmer (bis 31.12.17)Klaus Peter Gunsch (bis 31.12.17)Norman BaumgŠrtel (bis 30.04.17)Christine Huldi Andrea MusslerAntje HenkeAlice Wingerdt Bettina Andris Gabriela Rigotti (ab 01.04.17Nadine Mansueto (ab 01.09.17)Nicole KunstKristina Valaityte Daniele Minio Annette BusHeidi Linder Claudia KernbachBrigitta SorgNecla Demir (bis 30.04.17)Ayse Ulu (ab 01.09.17)Iris Klostermann (ab 01.11.17)
Team MTRA
Severine Dziergwa Nadine Ruettener Manuel Reidy Selina Botta Lea BurriStefan de Vries FrŠnzi Giger Barbara ImfeldMatthias Merz Katja Obhues Christine Orsingher Salome Seppi Kathrin Waidele Gina Wietschorke Feride Yesilyayla
21
Administration / Controlling
Team
Arton JusajRocio AlvarezEla AriBilal BektasMelanie JostJolanda MŸllerSarah RiglingAleksandra SchweizerChristina SchottGaby SchwobUrsula VogtHrvoje Vukovic
02 Kardiologie
22 21
Outcome Forschung
Team
Prof. Christian MŸllerDr. Ayman AlhussiniDr. Patrick BadertscherSanela BaracSara BarataPatrick BergsmaDr. Jasper BšddinghausDominik BreitenbŸcherLukas CrotonSebastian DietscheStephanie DšrflingerJeanne du Fay de LavallazPaul DuweDr. Ina FerelBrigitte FitzeDayana Flores GonzalesMichael FreeseMarc GeigerDominic GermanierBettina Glatz Dr. Beate HartmannNatascha Herr
02 Kardiologie / Klinische Forschung
Jonas HiltiUrsina HoneggerClaudia HuckRahel IsenrichJanina JannElif KeserIrina KlimmeckChristine KruseCaroline KulungaraDanai LaohachewinSabrina LauleSarah LšffelStella MarbotRomy MayrKathrin MeissnerFabiola M�tryDeborah MŸllerJulian PfŠffliDr. Christian PuelacherLea A. RichterichMarkus RiestererTherese Rinderknecht
Lorraine SazgaryDeborah SchneiderCarmela SchumacherJonas SchwarzDaniela SeebergerDr. Samyut ShrestaKristin ShrestaClaudia StelzigDr. Ivo StrebelKathrin ThommenDevran TopyŸrekMichael TschukJanine VšgeleJonas Elias WalterDesiree WusslerAna Yufera SanchezAndres Zimmerli
23
24
Swiss-AF Cohort Study
Team
Swiss-AF Cohort Study
Prof. Stefan OsswaldPD Dr. Michael KŸhneProf. Christian SticherlingProf. Christine Meyer-ZŸrnProf. David Conen Dr. Stefanie AeschbacherDr. Steffen BlumDr. Thomas KoflerDr. Philipp KrisaiDr. Christiane PudenzDr. Tobias SchšnDr. Anne Springer Sebastian BergerRaffaele BernasconiLucien EggimannLorin FršhlichTobias Gšldi Pascal Meyre
02 Kardiologie / Klinische Forschung
Michel MongiatAndreas ReusserAleksandra SchweizerSamuel StempfelGian Všllmin Von der CTU
Dr. Michael CoslovskyPascal BenkertPatrick Simon
23
Cardio Biology Team
Prof. Marijke BrinkChristian MorandiLifen XuPhilippe HeimGian R. Brouwer (seit Sept 2017)Hagena Thuraisingam (seit Sept 2017)Sonia Lebboukh (bis Okt 2017)Joseph Iharinjaka Randriamboavonjy (bis Sept 2017)
Myocardial Research Team
PD Dr. Gabriela Kuster PfisterPD Dr. Otmar PfisterVera Lorenz, M. Sc. Dr. Lifen XuDr. Michika Sato MochizukiGiacomo Della Verde, M. Sc. Daria Monogiou Belik, M. Sc.
Molecular Imaging Team
Prof. Beat KaufmannDr. Amanda Ochoa-EspinosaDr. Mukesh PunjabiDr. Lifen XuDr. David Steinl Alexandra Kosareva, M. Sc.
02 Kardiologie / Grundlagenforschung
25
Klinik fŸr Herzchirurgie
Team
�rzte
Prof. Friedrich Eckstein PD Dr. Oliver Reuthebuch Prof. Martin Grapow Dr. Florian RŸter PD Dr. Denis Berdajs Dr. Ulrich Schurr Alejandro Ramirez (01- 06/17) Rosalinda D`Amico (06 -12/17)
IMC Chirurgie
Dr. Pierre Branitzki (bis 05/17) Mairi Ziaka (ab 06/17)Dr. Clemens Dovifat Dr. Karin Fuhrmann-Hilbrecht Christina Ignat (ab 06/17)
03 Herzchirurgie
Fachassistenten Herzchirurgie
Andre Capitain (ab 08/17)Dr. Luca KoechlinAdriatik Komoni (04 - 07/17)Dr. Myroslava MytsykThibault Schaeffer (ab 12/17)Dr. Jasmin Hasmik Shahinian
Rotationsassistenten Chirurgie
Vladislav Borisov
Rotationsassistenten Kardiologie
Dr. Patrick Badertscher Dr. Marc HŠfliger
Rotationsassistenten Innere Medizin
Dr. Jasper BšddinghausLilian PichlerDr. Milos Radosavac
26 27
28
Klinik fŸr Herzchirurgie
Team
Physician Assistants
Waldemar GerrMahtab Jamshidpour (bis 06/17)
Kardiotechniker
Thomas DšbeleClaudia EndresSelin Korac (ab 08/17)Bejtush RrhamaniDr. Antoine Simons (bis 07/17)Urs Zenklusen
Forschungsgruppenteam
PD Dr. Anna MarsanoGiulia Cerino, PhDGiuseppe Isu, PhD Dr. Vladislav Borisov Dietlinde John-Steinberg Laia Gili Sole, MSc Alessia Pisanu, BSc Diana Robles Diaz Chirurgische Intermediate Care Station (IMC)
Vitomir JankovicAlexandra Murst
03 Herzchirurgie
Chirurgische Station 4.1
Marcel Hentz Fr�d�rique Foell Stv. Pflegedienstleitung (seit 06/17)Simon Scheifele (bis 05/17)Karin Steiger Alice Stšlke
Chirurgische Station 7.1
Sibylle Waldmann Silvia Violante
Sekretariat
Jolanda Giess Miriam Boughalmi Laura Voegeli Biljana Marti (ab 08/17) Brigitta Gahl (ab 06/17) Petra Vocat (bis 06/17) Bettina Kohler
2729
3130
Notfallzentrum
Team
�rzte Kader
Prof. Roland BingisserPD Dr. Christian NickelDr. Christoph BeckerDr. Michelle BrŠutigam Dr. Vera Freund Dr. Gerhard JŠckhDr. KriemhildLippayDr. Gregory MansellaDr. Caroline Polzer Dr. Elisabth RatzenbšckDr. Christiane RosinDr. Jana Steude Dr. Irena Straub Dr. Birgit WernerDr. Christian Beca Dr. Luc BlattmannDr. Nicolas Bless Dr. Peter Diel Dr. Gilbert KrŠhenbŸhl Dr. Sebastian MŸller
04 Notfallzentrum
Dr. Jochen RŸdiger Dr. Britta BussDr. Sonja CronenbergDr. Maria Gšttl
Pflege Kader
Katharina MatheisFranziska ImmbodenKai LŸbenDebbis AllenLilly Gavric
Administration
Monika Stadler
Contolling
Artur Stickel
Medizinische Intensivstation
Team
�rzte
Prof. Stephan Marsch Prof. Patrick Hunziker Dr. Andreas Christ Dr. Kai Tisljar Dr. Gianmarco Balestra Dr. Jorge KasperDr. Heidi LedererDr. Magnus StalderPD Dr. Raoul Sutteri
05 Medizinische Intensivstation
32
Pflege
Angelika Lehmann Monika Strohmeier Sabine Hiller Lukas Weibel Christian Emsden Marie-Noelle von AllmenJos� Lopes
Sekretariat
Deborah Minnig Silvia Habegger
33
34
KardioanŠsthesie
Team
�rzte
PD Dr. Jens Fassl PD Dr. Daniel Bolliger Dr. Joachim Erb Dr. Markus Maurer Dr. David Heppel Dr. Stefan Gisin Dr. Andreas Lampart Dr. Jonas Quitt Dr. Dominik Kallias
Pflegeteam
Isabelle Gisler Elisabeth Goustiaux Michael Gregor
06 KardioanŠsthesie
35
37
Operative Intensivbehandlung (OIB)
Team
�rzte
Prof. Hans ParggerProf. Martin SiegemundDr. Nadine CueniDr. Jan BittnerDr. Anita BoltresPD Dr. Andrea Kopp LugliDr. Andreas LŸdinDr. Benjamin MŸllerDr. Carole RimpauDr. Daniel TuchschererDr. Marianne Zumbrunn
07 Operative Intensivbehandlung (OIB)
36
Pflege
Michael WehrliClaudia SpychigerUrsula Barandun SchŠferConrad Wesch
Sekretariat
Janine Anliker
Lehre
08 Lehre
Weiter- und Fortbildungs-Veranstaltungen
Externe Weiter- und Fortbildung¥ Regionale Fortbildungskurse (Rheinfelden / Bad Bubendorf)
Interne Weiter- und Fortbildung¥ CCU-Rapport, tŠglich 08.00 Uhr¥ Kardiologie, Montag 08.15 Uhr¥ Herzchirurgie, Montag 07.30-08.00 Uhr¥ Departements Konferenz Chirurgie, Montag 08.10-9.00 Uhr¥ Echokardiographie Fortbildung, Montag 12.30-13.30 Uhr¥ Kardiochirurgisches und -medizinisches Meeting, Montag 17.00 Uhr¥ Curriculum AA, Dienstag 7.45 Uhr¥ Seminar KardiovaskulŠre Grundlagenforschung, 1x Monat, alternierend Mo 09.00-10.00 Uhr, bzw. Di 14.00-15.00 Uhr¥ Herzinsuffizienz Lunch, jeweils jeden dritten Dienstag im Monat 12.30-13.30 Uhr¥ Kardiochirurgisches und -medizinisches Meeting, Mittwoch, 17.00 Uhr¥ Kardio-Lunch, Donnerstag 12.30-13.30 Uhr¥ Journal Club, Freitag 08.15-9.00 Uhr¥ Mortality & Morbidity Conference, 1 x Monat, Freitag 12.30-13.30 Uhr¥ Problemorientierte Fall Tutorate (2. Jahreskurs Medizinische FakultŠt Basel)¥ Arzt-Patienten-Unterricht (4. und 6. Jahreskurs Medizinische FakultŠt Basel)
Selbstorganisierte Kongresse / Symposien der Kardiologie Basel
¥ medArt 2017, Juni 2017, Basel¥ EuroGuch Lausanne, 4.-6. Mai 2017¥ InteruniversitŠres GUCH-Kolloquium, 21. September 2017
Kongresse / Symposien mit Basler Hauptorganisation
¥ Basel Valve Summit 27.4.2017 (Prof. R. Jeger)¥ GREAT Meeting Rom, Juli 2017¥ "New Swiss Horizon" Electrophysiology-meeting Lenzerheide, 22./23.09.2017 ¥ DreilŠndertreffen Herzinsuffizienz Thun, 21.-23. September 2017¥ EKG Kurs fŸr Assistenten, 26./27.10.2017, Basel¥ EHRA Education Course - Implantable Cardioverter Defibrillator Module, Berlin, 16./17.11.2017
38
Einsitz in Standesorganisationen
¥ Prof. B. Kaufmann PrŠsident Arbeitsgruppe Echokardiographie und kardiovaskulŠre Bildgebung Mitglied Board Arbeitsgruppe kardiovaskulŠre Biologie Mitglied Finanzkommission SGK¥ Dr. T. Burkard: Revisor Schweizerische Hypertoniegesellschaft¥ Prof. F. Eckstein: VizeprŠsident im Vorstand der Schweizerischen Gesellschaft fŸr Herz- und Thorakale GefŠsschirurgie¥ Prof. R. Jeger: SGK Working Group Interventional Cardiology, Board Member¥ PD Dr. M. KŸhne Vorstandsmitglied Arbeitsgruppe Herzschrittmacher und Elektrophysiologie der SGK Ambassador for young electrophysiologists der EHRA (European Heart Rhythm Association)¥ PD Dr. G. Kuster Pfister: Mitglied Fachgruppe Frau & Herz der Schweiz. Herzstiftung, Cardiolinc Network, Member Board of Directors¥ Prof. Ch. MŸller Leiter, Dissertationsauszeichnungskommission der Medizinischen FakultŠt Basel European Society of Cardiology, Heart Failure Association, Board Member European Society of Cardiology, Biomarker Study Group, Member European Society of Cardiology, Acute Cardiovascular Care Association, Acute Heart Failure Study Group, chair European Society of Cardiology, Heart Failure Association, Committee on Diagnosis, chair European Society of Cardiology, Heart Failure Association, Committee on Acute Heart Failure, member GREAT Network, Vice president¥ PD Dr. O. Pfister: Past President Arbeitsgruppe Herzinsuffizienz der Schweizerischen Gesellschaft fŸr Kardiologie¥ PD Dr. O. Reuthebuch: Beisitzer im Vorstand der Schweizerischen Gesellschaft fŸr Herzchirurgie¥ Prof. B. SchŠr: Curriculumskommission der medizinischen FakultŠt Basel¥ Prof. C. Sticherling Mitglied des Scientific Writing Committees der European Heart Rhythm Association (EHRA) Past-PrŠsident der AG Herzschrittmacher und Elektrophysiologie der SGK Mitglied der Tarifkommission der SGK¥ PD Dr. D. Tobler Vorstandsmitglied WATCH (Working group teenager and adults with congenital heart disease) Vorstandsmitglied und PrŠsident herznetz.ch (Dachverband angeborene Herzfehler)¥ Prof. M. Zellweger: PrŠsident der SGK
Ausbildung
¥ Prof. M. Brink: Themenblockleiterin: Themenblock Herz Kreislauf, 2. Bachelor Studienjahr Themenblock Co-Leiterin, 1. Master Studienjahr Physiologie-Professorin (Vorlesungen, Praktika, Tutoriate)¥ Prof. M. Grapow: Tutoriat 1. JK, Betreuung von 3 Master Studenten, Betreuung von 1 Doktorandin¥ PD Dr. O. Reuthebuch: Betreuung von 2 Master Studenten¥ Prof. C. MŸller: Betreuung von 10 Masterstudenten / Tutoriat 4. JK / Betreuung von 14 Doktoranden¥ PD Dr. D. Tobler: Betreuung von 2 Masterstudenten¥ Prof. Ch. Kaiser, Prof. R. Jeger, PD Dr. T. Reichlin, Prof. B. SchŠr, PD Dr. C. Kuster Pfister: PrŸfer Staatsexamen¥ Prof. B. SchŠr: Themenblockorganisator¥ Prof. Ch. Sticherling, Prof. S. Osswald, Prof. B. SchŠr, PD Dr. M. KŸhne, PD Dr. T. Reichlin: EKG Kurs 39
Finanzielles
09 Finanzielles
ForschungsbeitrŠge
Schweizer Nationalfonds
¥ SNF Projektfšrderung 310030_149718: Kaufmann B. Non-invasive ultrasound molecular imaging of myocarditis and autoimmune myocardial inflammation Beginn: 01.04.2014 / 3 Jahre¥ SNF Projektfšrderung 310030_169905: Kaufmann B. Non-invasive ultrasound molecular imaging of atherosclerosis: development of a clinically translatable tracers for targeting of vascular cell adhesion molecule Beginn 01.01.2017 / 3 Jahre¥ SNF Professur Nr: PP00P3_133681: Conen D.: Risk factors and outcomes associated with the progression of human atrial fibrillation: Role of Inflammation, Oxidative Stress and Fibrosis in the Initiation and Progression of Human Atrial Fibrillation: 2011-2016 Beginn: 01.07.2011 / 5 Jahre¥ SNF Projektfšrderung 310030-169996: Brink M "Gender-specific mechanisms of cardiac dysfunction in obesity" Beginn 01.10.2016 / 3 Jahre¥ SNF Projektfšrderung 33IC30_166855/1: Tobler D. Effect of phosphodiesterase-5 inhibition with tadalafil on systemic right ventricular function - a multi-center, double-blindrandomized, placebo-controlled clinical trial Beginn: 01.01.2017 / 5 Jahre¥ SNF Projektfšrderung 156953: Kuster G./Pfister O. Regulators of cardiac progenitor cells: Focus on cancer drug targets Beginn / Dauer: 1.1.2016 / 3 Jahre¥ SWISS-AF (Longitudinal Studies): 33CS30_148474: Conen D., KŸhne M., Osswald S. Swiss Atrial Fibrillation Cohort Study Beginn: 01.03.2014 / 4 Jahre¥ SNF Projektfšrderung 310030_172989: Marsano A. Engineered patches for cardiac repair Beginn: 01.04.2017 / 4 Jahre ¥ SNF Projektfšrderung Nr. 32003B_159495/1: MŸller C. APACE Validation Beginn: 01.01.2016 / 3 Jahre¥ SNF Projektfšrderung 32003B_175604/1: MŸller C. BASEL IX Validation Beginn: 1.10.2017 / 3 Jahre¥ SNF Projektfšrderung Nr. 32473B_176178: KŸhne M. Health Consequences of the Burden of Atrial Fibrillation (Swiss-AF-Burden) Beginn: 01.10.2017 / 4 Jahre
40
EU-Grants
¥ 2013 European Union FP7-Health_2013_Innovation 1 (Project 602299), Sticherling C. EU-CERT-ICD Comparative effectiveness research to assess the use of primary prophylactic implantable cardioverter defibrillators in Europe Beginn: 1.10.2013 / 4 Jahre¥ European Union/Eurostars "E!9799 ALVALE, Anatomical Localization of the origin of Ventricular Arrhythmias from the 12-Lead ECG", Reichlin T Beginn: 01.01.2016 / 3 Jahre¥ European Union/Eurostars: Cebris, MŸller C. Combination of classical and high-frequency ECG with Biomarkers into a RiskScore for Exercise ECG Beginn: 01.10.2017 / 3 Jahre
Schweizerische Herzstiftung
¥ Rubini-G. M: Addressing gender-specific inequalties in the early diagnosis and management of acute cardiovascular diseases Beginn: 01.11.2016 / 1 Jahr¥ MŸller C.: Advantageous predictors of acute coronary syndromes evaluation (APACE, Phase III) Beginn: 01.11.2016 / 1 Jahr¥ Reichlin T.: Value of novel advanced 12-lead ECG markers for the selection of patients undergoing ICD implantation for primary prevention of sudden cardiac death Beginn: 01.01.2017 / 1 Jahr¥ KŸhne M.: Swiss-AF-Burden: Rhythm monitoring using 7-day ECG and implantable loop recorders Beginn: 1.10.2017 / 2 Jahre
Stiftung fŸr kardiovaskulŠre Forschung Basel
¥ Brink M., Burkard T., Conen D., Jeger R., Kaiser C., Kaufmann B., Kuster Pfister G., MŸller C., Pfister O., Reichlin T., Sticherling C., Zellweger M.
ForschungsbeitrŠge UniversitŠt Basel
¥ Mochizuki M.: Stay-on-track Beginn / Dauer: 01.08.2017 / 6 Monate
41
Finanzielles
09 Finanzielles
Andere Quellen / Stiftungen
¥ Goldschmidt-Jacobsen-Stiftung T. Reichlin: Refinement and Integration of Advanced ECG Technologies in Clinical Cardiology Beginn / Dauer: 1.4.2015 / 3 Jahre J. du Fay de Lavallaz: BASEL IX Beginn: 01.01.2017 / 1 Jahr¥ Kahane Foundation / Fondation Sana / Gesundheitsdepartement Basel-Stadt T. Burkard: "Nichtrauchen ist clever!" Fšrdermittel 2017
Andere Quellen / Industrie
¥ Abbott: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL VIII (MŸller C)¥ BASEL-PMI (MŸller C)¥ Beckman Coulter: APACE (MŸller C)¥ Biomerieux: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.)¥ BRAHMS: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL IX - Basel Syncope Evaluation Study (MŸller C.) BASEL V - Acute dyspnea (MŸller C.)¥ B. Braun Melsungen AG: BASKET-SMALL 2-Studie (Jeger R.)¥ Roche: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL V - Acute dyspnea (MŸller C.) GALACTIC (MŸller C.)¥ Siemens: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.)¥ Singulex: Advantageous predictors of acute coronary syndromes evaluation (APACE), (MŸller C.) BASEL VII - Acute Abdominal Pain (MŸller C.) Biochemical and electrocardiographic signatures to detect exercise-induced myocardial ischemia (MŸller C.) BASEL V, BASEL VIII, BASEL IX (MŸller C.)¥ VFWAWF-Pool RŸckkehrer-Stipendium, (Fahrni G.)
42
Sponsoren und Gšnner
¥ Abbott AG¥ Actelion Schweiz¥ A. Menarini AG¥ AstraZeneca AG¥ Bayer (Schweiz) AG¥ Biosense Webster¥ Biotronik Schweiz AG¥ Boehringer Ingelheim ¥ Boston Scientific¥ B.R.A.H.M.S. GmbH¥ B. Braun Melsungen AG¥ BŸhlmann Laborator AG¥ concile¥ Cordis Johnson & Johnson¥ Daiichi Sankyo (Schweiz) AG¥ 8sens biognostics GmbH¥ Edwards Life Science AG¥ Eli Lilly (Suisse) SA¥ Fšrderverein Kardiologie Basel¥ GlaxoSmithKline AG¥ GrŸnenthal Pharma AG¥ Guidant Europe SA¥ IBSA¥ J.C. General Serv. CVBA¥ Johnson & Johnson
¥ Medtronic (Schweiz) AG¥ mepha¥ Merck Sharp & Dohme¥ Mundipharma Medical Company¥ Novartis AG¥ novo nordisk¥ Nycomed Pharma AG¥ Pfizer AG¥ Robapharm AG¥ Roche¥ Sandoz Pharmaceuticals AG¥ Sanofi Aventis SA¥ Schwabe Pharma AG¥ Sigma-Tau Pharma AG¥ Stentys ¥ Stiftung fŸr kardiovaskulŠre Forschung Basel¥ St. Jude Medical (Schweiz) AG¥ Sorin ¥ Swiss Life AG¥ Takeda Pharma AG¥ Terumo ¥ The Medicines Company¥ Vifor Pharma¥ Viollier AG
43
Publikationen
Originalarbeiten
1. AbŠcherli R, Twerenbold R2, Boeddinghaus J2, Nestelberger T2, MŠchler P2, Sassi R3, Rivolta MW3, Roon izi EK3, Mainardi LT4, Kozhuharov N5, Rubini Gim�nez M2, Wildi K2, Grimm K2, Sabti Z2, Hillinger P2, Puelacher C2, Strebel I2, Cupa J2, Badertscher P2, Roux I2, Schmid R6, Leber R6, Osswald S2, Mueller C, Reichlin T. Diagnostic and prognostic values of the V-index, a novel ECG mar-ker quantifying spatial heterogeneity of ventricular repolarization, in patients with symptoms suggestive of non-ST-elevation myocardial infarction. Int J Cardiol. 2017. Impact Factor 6.189
2. Aimo A, Vergaro G, Ripoli A, Bayes-Genis A, Pascual Figal DA, de Boer RA, Lassus J, Mebazaa A, Gayat E, Breidthardt T, Sabti Z, Mueller C, Brunner-La Rocca HP, Tang WH, Grodin JL, Zhang Y, Bettencourt P, Maisel AS, Passino C, Januzzi JL, Emdin M.
3. Akoudad S, Dabiri Abkenari L, Schaer BA, Sticherling C, Levy WC, Jordaens L, Theuns DA. Comparison of multivariate risk esti-mation models to predict prognosis in patients with implantable cardioverter defibrillators with and without cardiac resynchroniza-tion therapy. Am J Cardiol 2017. Impact Factor 3.398
4. Ambavane A, Lindahl B, Giannitis E, Roiz J, Mendivil J, Fran-kenstein L, Body R, Christ M, Bingisser R, Alquezar A, Mueller C; TRAPID-AMI investigators. Economic evaluation of the one-hour rule-out and rule-in algorithm for acute myocardial infarction using the high-sensitivity cardiac troponin T assay in the emergency de-partment. PLoS One. 2017. Impact Factor 2.806
5. Asgar A, Chandrasekhar J, Mikhail G, Webb J, Lef�vre T, Tam-burino C, Hildick-Smith D, Hambrecht R, Van Belle E, Widder J, Dumonteil N, Hink U, Jeger R, Linke A, Deliargyris E, Gao P, Mehran R, Hengstenberg C, Anthopoulos P, Dangas G; BRAVO-3 Investiga-tors. Sex-based differences in outcomes with bivalirudin or unfrac-tionated heparin for transcatheter aortic valve replacement: Results from the BRAVO-3 randomized trial. Catheter Cardiovasc Interv. 2017. Impact Factor 2.602
6. Bahrmann P, Bertsch T, Giannitsis E, Christ M, Hofner B, Chris-tenson R, Lindahl B, Mueller C. Quantification of Renal Function and Cardiovascular Mortality in Patients Admitted to the Emergency Department with Suspected Acute Coronary Syndromes. Clin Lab. 2017. Impact Factor 0.840
10 Publikationen
7. Beri N, Marston NA, Daniels LB, Nowak RM, Schreiber D, Muel-ler C, Jaffe A, Diercks DB, Wettersten N, DeFilippi C, Peacock WF, Limkakeng AT, Anand I, McCord J, Hollander JE, Wu AH, Apple FS, Nagurney JT, Berardi C, Cannon CM, Clopton P, Neath SX, Chris-tenson RH, Hogan C, Vilke G, Maisel A. Necessity of hospitalization and stress testing in low risk chest pain patients. Am J Emerg Med. 2017. Impact Factor 1.494
8. Blum S, Muff C, Aeschbacher S, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Fischer A, Merkel T, KŸhne M Sticherling C, Osswald S, Conen D. Prospective assessment of sex-related differences in symptom status and health perception among patients with atrial fibrillation. J Am Heart Assoc 2017. Im-pact Factor 4.425
9. Boeddinghaus J, Nestelberger T, Twerenbold R, Wildi K, Badert-scher P, Cupa J, BŸrge T, MŠchler P, Corbi�re S, Grimm K, Gim�nez MR, Puelacher C, Shrestha S, Flores Widmer D, Fuhrmann J, Hil-linger P, Sabti Z, Honegger U, Schaerli N, Kozhuharov N, Rentsch K, Mir— ñ, L—pez B, Martin-Sanchez FJ, Rodriguez-Adrada E, Mora-wiec B, Kawecki D, Ganovská E, Parenica J, Lohrmann J, Kloos W, Buser A, Geigy N, Keller DI, Osswald S, Reichlin T, Mueller C. Direct Comparison of 4 Very Early Rule-Out Strategies for Acute Myocar-dial Infarction Using High-Sensitivity Cardiac Troponin I. Circulation. 2017 Impact Factor 19.309
10. Boeddinghaus J, Reichlin T, Nestelberger T, Twerenbold R, Meili Y, Wildi K, Hillinger P, Gim�nez MR, Cupa J, Schumacher L, Schu-bera M, Badertscher P, Corbi�re S, Grimm K, Puelacher C, Sabti Z, Widmer DF, Schaerli N, Kozhuharov N, Shrestha S, BŸrge T, MŠchler P, BŸchi M, Rentsch K, Mir— ñ, L—pez B, Martin-Sanchez FJ, Rodriguez-Adrada E, Morawiec B, Kawecki D, Ganovská E, Pa-renica J, Lohrmann J, Buser A, Keller DI, Osswald S, Mueller C. Early Diagnosis of Acute Myocardial Infarction in Patients with Mild Elevations of Cardiac Troponin. Clin Res Cardiol 2017. Impact Fac-tor 4.760
11. Bossard M, Knecht S, Aeschbacher S, Buechel R, Hochgruber T, Zimmermann A, Kessel-Schaefer A, Stephan FP, Voellmin G, Pra-della M, Sticherling C, Osswald S, Kaufmann B, Conen D, KŸhne M. Conventional versus 3D-echocardiography to predict arrhythmia re-currence after atrial fibrillation ablation. J Cardiovasc Electrophysiol 2017. Impact Factor 3.068
44
12. Bossard M, Th�riault S, Aeschbacher S, Schoen T, Kunz S, von Rotz M, Estis J, Todd J, Risch M, Mueller C, Risch L, Par� G, Conen D. Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population. Clin Res Cardiol 2017. Impact Factor 4.760
13. Breidthardt T, Sabti Z, Ziller R, Rassouli F, Twerenbold R, Kozhuh-arov N, Gayat E, Shrestha S, Barata S, Badertscher P, Boeddinghaus J, Nestelberger T, Mueller C. Diagnostic and prognostic value of cystatin C in acute heart failure. Clin Biochem. 2017. Impact Factor 2.434
14. Breidthardt T, Moreno-Weidmann Z, Uthoff H, Sabti Z, Appeli S, Puelacher C, Stallone F, Twerenbold R, Wildi K, Kozhuharov N, Wussler D, Flores D, Shrestha S, Badertscher P, Boeddinghaus J, Nestelberger T, Gimenez MR, Staub D, Aschwanden M, Lohrmann J, Pfister O, Osswald S, Mueller C. How accurate is clinical assess-ment of neck veins in the estimation of central venous pressure in acute heart failure? Insights from a prospective study. Eur J Heart Fail. 2018. in press. Impact Factor 6.968
15. Breidthardt T, Weidmann ZM, Twerenbold R, Gantenbein C, Stallone F, Rentsch K, Rubini Gimenez M, Kozhuharov N, Sabti Z, BreitenbŸcher D, Wildi K, Puelacher C, Honegger U, Wagener M, Schumacher C, Hillinger P, Osswald S, Mueller C. Impact of Haemo-concentration during Acute Heart Failure Therapy on Mortality and its Relationship with Worsening Renal Function. Eur J Heart Fail 2017. Impact Factor 6.968
16. Brenner R, Ammann P, Yoon SI, Christen S, Hellermann J, Girod G, Knaus U, Duru F, Krasniqi N, Ramsay D, Sticherling C, Lippuner, KŸhne M. Reduction of falls and fractures after permanent pace-maker implantation in elderly patients with sinus node dysfunction. Europace 2017. Impact Factor 4.530 17. Burri H, MŸller H, Kobza R, Sticherling C, Ammann P, Zerlik H, Stettler C, Klersy C, Prinzen A, Auricchio A. Right versus left apical transvenous pacing for bradycardia: results of the RIVELA rando-mized study. Ind Pacing Electrophysiol J.
18. Burkard T, Winterhalder C, Leonardi L., Maseli A, Schoen T, Eck-stein J, Vischer AS. Missed arterial hypertension by office blood pressure measurement measured according to the NICE 2011 guidelines - Results from the iPARR trial. Journal of Hypertension 2017. Impact Factor 4.085
19. Caobelli F*, Haaf P*, Chronis J, Haenny G, Brinkert M, Pfisterer ME, Zellweger MJ; Basel Asymptomatic High-Risk Diabetics Out-come Trial (BARDOT) Investigators. Prognostic Usefulness of Cardi-ac Stress Test Modalities in Patients With Type 2 Diabetes Mellitus Who Underwent Myocardial Perfusion Scintigraphy (from the Basel Asymptomatic High-Risk Diabetics Outcome Trial). Am J Cardiol. 2017. Impact Factor 3.398
20. Celikyurt U, Knecht S, Kuehne M, Reichlin T, Muehl A, Osswald S, Sticherling C. Incidence of new-onset atrial fibrillation after cavo-tricuspid isthmus ablation for atrial flutter. Europace 2017. Impact Factor 4.530
21. Chapman A, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, Andrews J, Tan S, Cheng SF, D'Souza M, Orme K, Strachan FE, Nestelberger T, Twerenbold R, Badertscher P, Reichlin T, Gray A, Shah ASV, Mueller C, Newby DE, Mills NL. Comparison of the efficacy and safety of early rule out pathways for acute myo-cardial infarction. Circulation 2017. Impact Factor 19.309
22. Chapman AR, Lee KK, McAllister DA, Cullen L, Greenslade JH, Parsonage W, Worster A, Kavsak PA, Blankenberg S, Neumann J, Sšerensen NA, Westermann D, Buijs MM, Verdel GJE, Picke-ring JW, Than MP, Twerenbold R, Badertscher P, Sabti Z, Mueller C, Anand A, Adamson P, Strachan FE, Ferry A, Sandeman D, Gray A, Body R, Keevil B, Carlton E, Greaves K, Korley FK, Metkus TS, Sandoval Y, Apple FS, Newby DE, Shah ASV, Mills NL. Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome. JAMA. Review. Impact Factor 44.405
23. Cerino G, Gaudiello E, Muraro MG, Eckstein F, Martin I, Scher-berich A, Marsano A. Engineering of an angiogenic niche by perfu-sion culture of adipose-derived stromal vascular fraction cells. Sci Rep. 2017. Impact Factor 4.259
24. Conen D, Rodondi N, Mueller A, Beer J, Auricchio A, Ammann P, Hayoz D, Kobza R, Moschovitis G, Shah D, Schlaepfer J, Novak J, di Valentiono M, Erne P, Sticherling C, Bonati L, Ehret G, Roten L, Fischer U, Monsch A, Stippich C, Wuerfel J, Schwenkglenks M, Kuehne M, Osswald S. Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillation. Swiss Med Wkly 2017. Im-pact Factor 1.654
45
Publikationen
10 Publikationen
31. Fahrni G, Wolfrum M, De Maria GL, Cuculi F, Dawkins S, Alkhalil M, Patel N, Forfar JC, Prendergast BD, Choudhury RP, Channon KM, Banning AP, Kharbanda RK. Index of Microcirculatory Resis-tance at the Time of Primary Percutaneous Coronary Intervention Predicts Early Cardiac Complications: Insights From the OxAMI (Oxford Study in Acute Myocardial Infarction) Cohort. J Am Heart Assoc. 2017. Impact Factor 5.117
32. Ferko N, Ferrante G, Hasegawa JT, Schikorr T, Soleas IM, Hern-andez JB, Sabat� M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Valgi-migli M. Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized tri-als. Catheter Cardiovasc Interv. 2017. Impact Factor 2.602
33. Fischer A, Bossard M, Aeschbacher S, Egli P, Cordewener C, Estis J, Todd J, Risch M, Risch L, Conen D., Plasma levels of endo-thelin-1 and renal function among young and healthy adults. Clin Chem Lab Med 2017. Impact Factor
34. Gaudiello E, Melly L, Cerino G, Boccardo S, Jalili-Firoozinezhad S, Xu L, Eckstein F, Martin I, Kaufmann BA, Banfi A, Marsano A. Scaffold Composition Determines the Angiogenic Outcome of Cell-Based Vas-cular Endothelial Growth Factor Expression by Modulating Its Microen-vironmental Distribution. Adv Healthc Mater. 2017. Impact Factor 5.110
35. Garg P, Broadbent DA, Swoboda PP, Foley JRJ, Fent GJ, Musa TA, Ripley DP, Erhayiem B, Dobson LE, McDiarmid AK, Haaf P, Ki-dambi A, van der Geest RJ, Greenwood JP, Plein S. Acute Infarct Extracellular Volume Mapping to Quantify Myocardial Area at Risk and Chronic Infarct Size on Cardiovascular Magnetic Resonance Imaging. Circ Cardiovasc Imaging. 2017. Impact Factor 6.803
36. Garg P, Broadbent DA, Swoboda PP, Foley JRJ, Fent GJ, Musa TA, Ripley DP, Erhayiem B, Dobson LE, McDiarmid AK, Haaf P, Ki-dambi A, Crandon S, Chew PG, van der Geest RJ, Greenwood JP, Plein S. Extra-cellular expansion in the normal, non-infarcted myo-cardium is associated with worsening of regional myocardial func-tion after acute myocardial infarction. J Cardiovasc Magn Reson. 2017. Impact Factor 5.601
37. Garg P, Kidambi A, Swoboda PP, Foley JR, Musa TA, Rip-ley DP, Erhayiem B, Dobson LE, McDiarmid AK, Fent GJ, Haaf P, Greenwood JP, Plein S. The role of left ventricular deformation in the assessment of microvascular obstruction and intramyocardial haemorrhage. Int J Cardiovasc Imaging. 2017. Impact Factor 1.896
25. De Boeck BW, Toma A, Kiencke S, Dehnert C, ZŸgel S, Sieben-mann C, Auinger K, Buser PT, Maggiorini M, Kaufmann BA. Altered left ventricular geometry and torsional mechanics in high altitude-induced pulmonary hypertension: a 3D echocardiographic study. J Am Soc Echocardiogr. Impact Factor 6.852
26. De Maria GL, Alkhalil M, Wolfrum M, Fahrni G, Borlotti A, Gaughran L, Dawkins S, Langrish JP, Lucking AJ, Choudhury RP, Porto I, Crea F, Dall‘Armellina E, Channon KM, Kharbanda RK, Ban-ning AP. The ATI score (age-thrombus burden-index of microcircula-tory resistance) determined during primary percutaneous coronary intervention predicts final infarct size in patients with ST-elevation myocardial infarction: a cardiac magnetic resonance validation stu-dy. EuroIntervention. 2017. Impact Factor 5.165
27. De Maria GL, Patel N, Wolfrum M, Fahrni G, Kassimis G, Porto I, Dawkins S, Choudhury RP, Forfar JC, Prendergast BD, Channon KM, Kharbanda RK, Garcia-Garcia HM, Banning AP. The influence of coronary plaque morphology assessed by optical coherence to-mography on final microvascular function after stenting in patients with ST-elevation myocardial infarction. Coron Artery Dis. 2017. Im-pact Factor 1.823
28. De Waard GA, Fahrni G, de Wit D, Kitabata H, Williams R, Patel N, Teunissen PF, van de Ven PM, Umman S, Knaapen P, Perera D, Akasaka T, Sezer M, Kharbanda RK, van Royen N. Hyperaemic mi-crovascular resistance predicts clinical outcome and microvascular injury after myocardial infarction. Heart. 2017. Impact Factor 6.059
29. Dobson LE, Musa TA, Uddin A, Fairbairn TA, Bebb OJ, Swoboda PP, Haaf P, Foley J, Garg P, Fent GJ, Malkin CJ, Blackman DJ, Plein S, Greenwood JP. The impact of trans-catheter aortic valve replace-ment induced left-bundle branch block on cardiac reverse remodel-ling. J Cardiovasc Magn Reson. Impact Factor 5.601
30. Faggioni M, Baber U, Afshar AE, Giustino G, Sartori S, Sorren-tino S, Steg PG, Stefanini GG, Windecker S, Leon MB, Stone GW, Wijns W, Serruys PW, Valgimigli M, Camenzind E, Weisz G, Smits PC, Kandzari DE, Galatius S, Von Birgelen C, Jeger RV, Mikhail GW, Itchhaporia D, Mehta L, Ortega R, Kim HS, Kastrati A, Chieffo A, Dangas GD, Morice MC, Mehran R. Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From a Pa-tient-Level Pooled Analysis of Randomized Controlled Trials. JACC Cardiovasc Interv. 2017. Impact Factor 8.841
46
45. Hengstenberg C, Chandrasekhar J, Sartori S, Lefevre T, Mik-hail G, Meneveau N, Tron C, Jeger R, Kupatt C, Vogel B, Farhan S, Sorrentino S, Sharma M, Snyder C, Husser O, Boekstegers P, Hambrecht R, Widder J, Hildick-Smith D, De Carlo M, Wijngaard P, Deliargyris E, Bernstein D, Baber U, Mehran R, Anthopoulos P, Dan-gas G; BRAVO-3 Investigators. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial. Catheter Cardiovasc Interv. 2017. Impact Factor 2.602
46. Herrero-Puente P, Prieto-Garc“a B, García-Garc“a M, Llorens P, Mart“n-S‡nchez FJ, Jacob J, Mebazaa A, Mueller C, Maisel AS, Gil V, Garc“a-Hernandez P, Mir— ñ. The relationship of circulating re-laxin-2 concentrations with short-term prognosis in patients with acute heart failure. The RELAHF study. Eur J Heart Fail 2017 [Epub ahead of print]. Impact Factor 6.968
47. Hillinger P, Twerenbold R, Wildi K, Rubini Gimenez M, Jaeger C, Boeddinghaus J, Nestelberger T, Grimm K, Reichlin T, Stallone F, Pu-elacher C, Sabti Z, Kozhuharov N, Honegger U, Ballarino P, Miro O, Denhaerynck K, Ekrem T, Kohler C, Bingisser R, Osswald S, Mueller C.Gender-specific Uncertainties in the Diagnosis of Acute Coronary Syndrome. Clin Res Cardiol 2017. Impact factor 4.8
48. Iglesias JF, Muller O, Zaugg S, Roffi M, Kurz DJ, Vuilliomenet A, Weilenmann D, Kaiser C, Tapponnier M, Heg D, Valgimigli M, Eeck-hout E, JŸni P, Windecker S, Pilgrim T. A comparison of an ultrathin strut biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent for patients with acute stsegment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the BIOSTEMI trial. Eurointervention 2017. Impact Factor 5.165
49. Jacob J, Roset A, Mir— ñ, Alqu�zar A, Herrero P, Mart’n-San-chez FJ, Mšckel M, MŸller C, Llorens P. TROPICA-2 Study. Prog-nostic value of troponin in patients with acute heart failure treated in Spanish hospital emergency services. Biomarkers 2017. Impact Factor 2.016
50. Jatene T, Biering-S¿rensen T, Nochioka K, Mangione FM, Han-sen KW, S¿rensen R, Jensen JS, J¿rgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators. Frequency of Cardiac Death and Stent Thrombosis in Patients With Chronic Ob-structive Pulmonary Disease Undergoing Percutaneous Coronary Intervention (from the BASKET-PROVE I and II Trials). Am J Cardiol 2017. Impact Factor 3.398
38. Gayat E, Arrigo M, Littnerova S, Sato N, Parenica J, Ishihara S, Spinar J, MŸller C, Harjola VP, Lassus J, Mir— ñ, Maggioni AP, AlHabib KF, Choi DJ, Park JJ, Zhang Y, Zhang J, Januzzi JL Jr, Kaji-moto K, Cohen-Solal A, Mebazaa A; GREAT Network. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study. Eur J Heart Fail 2017. Impact Factor 6.968
39. Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, Windecker S, Serruys PW, Kastrati A, Von Birgelen C, Kimura T, Ste-fanini GG, Dangas GD, Wijns W, Steg PG, Morice MC, Camenzind E, Weisz G, Smits PC, Sorrentino S, Sharma M, Farhan S, Faggioni M, Kandzari D, Galatius S, Jeger RV, Valgimigli M, Itchhaporia D, Mehta L, Kim HS, Chieffo A, Mehran R. Long-term Safety and Effi-cacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration. JAMA Cardiol. 2017
40. Grapow M, Haug M, Tschung C, Winkler B, Banerjee P, Heinisch PP, Fassl J, Reuthebuch O, Eckstein F. Therapy options in deep ster-nal wound infection: Sternal plating versus muscle flap. PLoS One. 2017. Impact Factor 2.806
41. Greenslade JH, Adikari T, Mueller C, Sandoval Y, Nestelberger T, Parsonage W, Hawkins T, Cullen L. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study. Emerg Med J. 2017. Impact Factor 1.861
42. Gualandro DM, Puelacher C, Lurati Buse G, Llobet GB, Yu PC, Cardozo FA, Glarner N, Zimmerli A, Espinola J, Corbi�re S, Caldera-ro D, Marques AC, Casella IB, de Luccia N, Oliveira MT, Lampart A, Bolliger D, Steiner L, Seeberger M, Kindler C, Osswald S, Gürke L, Caramelli B, Mueller C; GREAT network. Prediction of major cardiac events after vascular surgery. J Vasc Surg. 2017. Impact Factor 3.545
43. GŸnther F, Heidt T, Kramer M, Khanicheh E, Klibanov AL, Geibel-Zehender A, Ferrante EA, Hilgendorf I, Wolf D, Zirlik A, Reinšhl J, Bode C, Peter K, Kaufmann BA*, MŸhlen CVZ*. Dual targeting im-proves capture of ultrasound microbubbles towards activated pla-telets but yields no additional benefit for imaging of arterial throm-bosis. Sci Rep. 2017. Impact Factor 4.259
44. Haaf P, Ritter M, Grize L, Pfisterer ME, Zellweger MJ; BARDOT study group. Quality of life as predictor for the development of car-diac ischemia in high-risk asymptomatic diabetic patients. J Nucl Cardiol. 2017. Impact Factor 3.930
47
Publikationen
10 Publikationen
59. Koskinas KC, Taniwaki M, Rigamonti F, Heg D, Roffi M, TŸller D, Muller O, Vuillomenet A, Cook S, Weilenmann D, Kaiser C, Jams-hidi P, JŸni P, Windecker S, Pilgrim T. Impact of Patient and Lesion Complexity on Long-Term Outcomes Following Coronary Revascu-larization With New-Generation Drug-Eluting Stents. Am J Cardiol. 2017. Impact Factor 3.398
60. Krivoshei L, Weber S, Burkard T, Maseli A, Brasier N, KŸhne M, Conen D, Huebner T, Seeck A and Eckstein J. Smart detection of atrial fibrillation. Europace. 2017. Impact Factor 4.530
61. Laribi S, Pemberton CJ, Kirwan L, Nouira S, Turkdogan K, Yilmaz MB, Troughton RW, Gayat E, Rivas-Lasarte M, Sadoune M, Sabti Z, Hansconrad E, Motiejunaite J, Plaisance P, Beshiri A, Chen W, Collet C, FitzGerald JM, Mueller C, Launay JM, Richards M, Me-bazaa A; GREAT (Global Research on Acute Conditions Team) Net-work. Mortality and acute exacerbation of COPD: a pilot study on the influence of myocardial injury. Eur Respir J. 2017. Impact Factor 10.569
62. Legrand M, Ludes PO, Massy Z, Rossignol P, Parenica J, Park JJ, Ishihara S, AlHabib KF, Maggioni A, Mir— ñ, Sato N, Cohen-Solal A, Fairman E, Lassus J, Harjola VP, Mueller C, Peacock FW, Choi DJ, Plaisance P, Spinar J, Kosiborod M, Mebazaa A, Gayat E; GREAT (Global Research on Acute Conditions Team) Network and INI-CRCT (Investigation Network Initiative-Cardiovascular and Re-nal Clinical Trialists) network. Association between hypo- and hy-perkalemia and outcome in acute heart failure patients: the role of medications. Clin Res Cardiol. 2017 [Epub ahead of print]. Impact Factor 4.760
63. Lindahl B, Jernberg T, Badertscher P, Boeddinghaus J, Eggers KM, Frick M, Rubini Gimenez M, Linder R, Ljung L, Martinsson A, Melki D, Nestelberger T, Rentsch K, Reichlin T, Sabti Z, Schubera M, Svensson P, Twerenbold R, Wildi K, Mueller C. An algorithm for rule-in and rule-out of acute myocardial infarction using a novel Troponin I assay. Heart 2017. Impact Factor 6.059
64. Liu D, Borlotti A, Viliani D, Jerosch-Herold M, Alkhalil M, De Maria GL, Fahrni G, Dawkins S, Wijesurendra R, Francis J, Ferreira V, Piechnik S, Robson MD, Banning A, Choudhury R, Neubauer S, Channon K, Kharbanda R, Dall'Armellina E. CMR Native T1 Map-ping Allows Differentiation of Reversible Versus Irreversible Myo-cardial Damage in ST-Segment-Elevation Myocardial Infarction: An OxAMI Study (Oxford Acute Myocardial Infarction). Circ Cardiovasc Imaging. 2017. Impact Factor 6.803
51. Jeger JR, Pfister O, Radovanovic D, Eberli FR, Rickli H, Urban P, Pedrazzini G, Stauffer JC, Nossen J, Erne P, for the AMIS-Plus Inves-tigators (*joint first authorship). Heart failure in patients admitted for acute coronary syndromes: A report from a large national registry. Clin Cardiol. 2017. Impact Factor 2.757
52. Jekova I, Krasteva V, Leber R, Schmid R, Twerenbold R, MŸller C, Reichlin T, AbŠcherli R. A Correction Formula for the ST Segment Measurements for the AC-coupled Electrocardiograms. IEEE Tran-sactions on Biomedical Engineering 2017. Impact Factor 1,29.
53. Jekova I, Krasteva V, Leber R, Schmid R, Twerenbold R, MŸller C, Reichlin T, AbŠcherli R. IBiomedical Signal Processing and Con-trol 2017; in press. Impact Factor 1.521.
54. Kaier TE, Twerenbold R, Puelacher C, Marjot J, Imambaccus N, Boeddinghaus J, Nestelberger T, Badertscher P, Sabti Z, Gim�nez MR, Wildi K, Hillinger P, Grimm K, Loeffel S, Shrestha S, Widmer DF, Cupa J, Kozhuharov N, Mir— ñ, Mart’n-S‡nchez FJ, Morawiec B, Rentsch K, Lohrmann J, Kloos W, Osswald S, Reichlin T, Weber E, Marber M, Mueller C. Direct comparison of cardiac myosin-binding protein C to cardiac troponins for the early diagnosis of acute myo-cardial infarction. Circulation 2017. Impact Factor 19.309
55. Knecht S, Burch F, Reichlin T, Spies F, MŸhl A, Altmann D, Am-mann P, Schaer B, Osswald S, Sticherling C, KŸhne M. First clini-cal experience of a dedicated irrigated-tip radiofrequency ablation catheter for the ablation of cavotricuspid isthmus-dependent atrial flutter. Clin Res Cardiol 2017. Impact Factor 4.760
56. Knecht S, Pradella M, Reichlin T, MŸhl A, Bossard M, Stieltjes B, Conen D, Bremerich J, Osswald S, KŸhne M, Sticherling C. Left at-rial anatomy, atrial fibrillation burden and P-wave duration - relation-ships and predictors for single procedure success after pulmonary vein isolation. Europace 2017. Impact Factor 4.521
57. Knecht S, Sticherling C, Reichlin T, MŸhl A, Pavlovic N, Schaer B, Osswald S, KŸhne M. Reliability of luminal oesophageal temperature monitoring during radiofrequency ablation of atrial fibrillation: insights from probe visualization and oesophageal reconstruction using mag-netic resonance imaging. Europace 2017. Impact Factor 4.521
58. Kofler T, Th�riault S, Bossard M, Aeschbacher S, Bernet S, Krisai P, Blum S, Risch M, Risch L, Albert CM, Par� G, Conen D. Relati-onships of Measured and Genetically Determined Height With the Cardiac Conduction System in Healthy Adults. Circ Arrhythm Elec-trophysiol, 2017. Impact Factor
48
65. Maier A, Plaza-Heck P, Meixner F, Guenther F, Kaufmann BA, Kramer M, Heidt T, Zirlik A, Hilgendorf I, Reinšhl J, Stachon P, Bron-sert P, Birkemeyer R, Neudorfer I, Peter K, Bode C, von Zur MŸhlen C. A molecular intravascular ultrasound contrast agent allows de-tection of activated platelets on the surface of symptomatic human plaques. Atherosclerosis. 2017. Impact factor 4.239
66. Maseli A, Aeschbacher S, Schoen T, Fischer A, Jung M, Risch M, Risch L, Conen D. Healthy Lifestyle and Blood Pressure Variabili-ty in Young Adults. Am J Hypertens, 2017. Impact Factor
67. Mangione FM, Biering-S¿rensen T, Nochioka K, Jatene T, Sil-vestre OM, Hansen KW, S¿rensen R, Jensen JS, Jorgensen PG, Jeger R, Kaiser C, Pfisterer M, Galatius S. Second generation drug-eluting stents versus bare-metal stents for percutaneous corona-ry intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials. Catheter Cardiovasc Interv. 2017. [Epub ahead of print] Impact Factor 2.602
68. Mart’n-S‡nchez FJ, Rodr’guez-Adrada E, Mueller C, Vid‡n MT, Christ M, Peacock WF, Rizzi MA, Alquezar A, Pi–era P, Lˆzaro Aragues P, Llorens P, Herrero P, Jacob J, Fern‡ndez C, Mir— ñ. The effect of frailty on 30-day mortality risk in older patients with acute heart failure attended in the Emergency Department. Acad Emerg Med J. 2017. Impact Factor 1.861
69. Matt P, Banerjee P, Grapow M, Rueter F, Schurr U, Siegemund M, Fassl J, Reuthebuch O, Eckstein F. Modified frozen elephant trunk for acute type A aortic dissection: a comparative study with standard repair technique. Eur J Cardiothorac Surg. 2017. Impact Factor 3.759
70. Mueller-Hennessen M, Mueller C, Giannitsis E, Biener M, Vafaie M, deFilippi CR, Christ M, Ord—–ez-Llanos J, Panteghini M, Plebani M, Verschuren F, Melki D, French JK, Christenson RH, Body R, Mc-Cord J, Dinkel C, Katus HA, Lindahl B for the TRAPID-AMI Investi-gators. Serial Sampling of High-Sensitivity Cardiac Troponin T May Not Be Required for Prediction of Acute Myocardial Infarction Dia-gnosis in Chest Pain Patients with Highly Abnormal Concentrations at Presentation. Clin Chemistry 2017. Impact Factor 8.008
71. McCord J, Cabrera R, Lindahl B, Giannitsis E, Evans K, Nowak R, Frisoli T, Body R, Christ M, deFilippi CR, Christenson RH, Jacob-sen G, Alquezar A, Panteghini M, Melki D, Plebani M, Verschuren F, French J, Bendig G, Weiser S, Mueller C; TRAPID-AMI Investiga-torsPrognostic Utility of a Modified HEART Score in Acute Chest Pain Patients. Circulation: Cardiovascular Quality & Outcomes 2017. Impact Factor 4.282
72. Mir— ñ, Gonz‡lez de la Presa B B, Herrero P, Fern‡ndez Boni-facio R, Mšckel M, Mueller C, Casals G, Sandalinas S, Llorens P, Mart’n-S‡nchez FJ, Jacob J, Bedini JL, Gil V. The GALA study: Rela-tionship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure. Biomarkers 2017. [Epub ahead of print]. Impact Factor 2.016
73. Mochizuki M, Lorenz V, Ivanek R, Della Verde G, Gaudiello E, Marsano A, Pfister O, Kuster GM. Polo-like kinase 2 is dynamically regulated to coordinate proliferation and early lineage specification downstream of yes-associated protein 1 in cardiac progenitor cells. J Am Heart Assoc. 2017. Impact Factor 5.117
74. Musa TA, Uddin A, Swoboda PP, Fairbairn TA, Dobson LE, Singh A, Garg P, Steadman CD, Erhayiem B, Kidambi A, Ripley DP, McDi-armid AK, Haaf P, Blackman DJ, Plein S, McCann GP, Greenwood JP. Cardiovascular magnetic resonance evaluation of symptomatic severe aortic stenosis: association of circumferential myocardial strain and mortality. J Cardiovasc Magn Reson. 2017. Impact Fac-tor 5.601
75. Nazerian P, Mueller C, de Matos Soeiro A, Leidel BA, Salvadeo SAT, Giachino F, Vanni S, Grimm K, Oliveira MT Jr, Pivetta EE, Lupia E, Grifoni S, Morello F; ADvISED Investigators. Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acu-te Aortic Syndromes: The ADvISED Prospective Multicenter Study. Circulation. Impact Factor 19.309
76. Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Wildi K, BreitenbŸcher D, Sabti Z, Puelacher C, Rubini Gim�nez M, Kozhuharov N, Strebel I, Sazgary L, Schneider D, Jann J, du Fay de Lavallaz J, Mir— ñ, Martin-Sanchez FJ, Morawiec B, Kawecki D, Mu-zyk P, Keller DI, Geigy N, Osswald S, Reichlin T, Mueller C; APACE Investigators. Effect of Definition on Incidence and Prognosis of Type 2 Myocardial Infarction Journal of the American College of Cardiology 2017. Impact Factor 19.896
77. Ng LL, Squire IB, Jones DJ, Cao TH, Chan DC, Sandhu JK, Quinn PA, Davies JE, Struck J, Hartmann O, Bergmann A, Mebazaa A, Gayat E, Arrigo M, Akiyama E, Sabti Z, Lohrmann J, Twerenbold R, Herrmann T, Schumacher C, Kozhuharov N, Mueller C. Proenke-phalin, prediction of renal dysfunction and short and longer term prognosis in acute heart failure - a GREAT network study. J Am Coll Cardiol 2017. Impact Factor 19.896
49
Publikationen
10 Publikationen
84. Puelacher C, Lurati Buse G, Seeberger D, Sazgary L, Marbot S, Lampart A, Espinola J, Kindler C, Hammerer A, Seeberger E, Stre-bel I, Wildi K, Twerenbold R, du Fay de Lavallaz J, Steiner L, Gurke L, Breidthardt T, Rentsch K, Buser A, Gualandro DM, Osswald S, Mueller C, for the BASEL-PMI Investigators. Perioperative myocar-dial injury after non-cardiac surgery: incidence, mortality and cha-racterization. Circulation 2017. [Epub ahead of print.] Impact Factor 19.309
85. Puelacher C, Wagener M, AbŠcherli R, Honegger U, Lhasam N, Schaerli N, Pr�tre G, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Rubini Gim�nez M, Hillinger P, Wildi K, Sabti Z, Ba-dertscher P, Cupa J, Kozhuharov N, du Fay de Lavallaz J, Freese M, Roux I, Lohrmann J, Leber R, Osswald S, Wild D, Zellweger MJ, Mueller C, Reichlin T. Diagnostic value of ST-segment deviations during cardiac exercise stress testing: Systematic comparison of different ECG leads and time-points. Int J Cardiol 2017. Impact Fac-tor 6.189
86. Puelacher C, Wagener M, Honegger U, Assadian M, Schaerli N, Mueller D, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Wildi K, Sabti Z, Sazgary L, Badertscher P, du Fay de Lavallaz J, Marbot S, Kaiser C, Wild D, Zellweger MJ, Reichlin T, Mueller C. Combining high-sensitivity cardiac troponin and B-type natriuretic peptide in the detection of inducible myocardial ischemia. Clin Bio-chem. 2017. Impact Factor 2.434.
87. Remy MM, Sahin M, Flatz L, Regen T, Xu L, Kreutzfeldt M, Fal-let B, Doras C, Rieger T, Bestmann L, Hanisch UK, Kaufmann BA, Merkler D, Pinschewer DD. Interferon'Driven iNOS: A Molecular Pathway to Terminal Shock in Arenavirus Hemorrhagic Fever. Cell Host Microbe. 2017. Impact Factor 14.946.
88. Reusser A, Blum S, Aeschbacher S, Eggimann L, Ammann P, Erne P, Moschovitis G, Di Valentino M, Shah D, SchlŠpfer J, Manser S, Reichlin T, KŸhne M, Sticherling C, Osswald S, Conen D. QTc interval, cardiovascular events and mortality in patients with atrial fibrillation. Int J Cardiol 2018, Epub 2017. Impact Factor 6.189
89. Rickenbacher P, Kaufmann BA, Maeder MT, Bernheim A, Goe-tschalckx K, Pfister O, Pfisterer M, Brunner-La Rocca HP; TIME-CHF Investigators. Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Eur J Heart Fail. 2017. Impact Factor 6.968.
78. Noble S, Stortecky S, Heg D, Tueller D, Jeger R, Toggweiler S, Ferrari E, Nietlispach F, Taramasso M, Maisano F, GrŸnenfelder J, JŸni P, Huber C, Carrel T, Windecker S, Wenaweser P, Roffi M. Com-parison of procedural and clinical outcomes with Evolut R versus Medtronic CoreValve: a Swiss TAVI registry analysis. EuroInterven-tion. 2017. Impact Factor 5.165
79. Nochioka K, Biering-S¿rensen T, Hansen KW, S¿rensen R, Pe-dersen S, J¿rgensen PG, Iversen A, Shimokawa H, Jeger R, Kaiser C, Pfisterer M, Galatius S; BASKET-PROVE Investigators. Long-term outcomes in patients with rheumatologic disorders undergoing per-cutaneous coronary intervention: a BAsel Stent Kosten-EffektivitŠts Trial-PROspective Validation Examination (BASKET-PROVE) sub-study. Eur Heart J Acute Cardiovasc Care. 2017
80. Nowak R, Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, DeFilippi C, McCord J, Body R, Panteghini M, Jernberg T, Plebani M, Verschuren F, French J, Christenson, Jacobsen G, Dinkel C, Lin-dahl B.. High sensitivity cardiac troponin T in patients not having an acute coronary syndrome: Results from the TRAPID-AMI study. Biomarkers 2017. Impact Factor 2.006
81. Pedrazzini GB, Ferrari E, Zellweger M, Genoni M. Heart Team: Joint Position of the Swiss Society of Cardiology and the Swiss Society of Cardiac Surgery. Thorac Cardiovasc Surg. 2017. Impact Factor 4.446
82. Pickering JW, Than MP, Cullen L, Aldous S, Ter Avest E, Body R, Carlton EW, Collinson P, Dupuy AM, Ekelund U, Eggers KM, Flor-kowski CM, Freund Y, George P, Goodacre S, Greenslade JH, Jaffe AS, Lord SJ, Mokhtari A, Mueller C, Munro A, Mustapha S, Parso-nage W, Peacock WF, Pemberton C, Richards AM, Sanchis J, Staub LP, Troughton R, Twerenbold R, Wildi K, Young J. Rapid Rule-out of Myocardial Infarction with a High-sensitivity Cardiac Troponin T measurement below the limit of detection: A collaborative meta-analysis. Ann Intern Med 2017. [Epub ahead of print]. Impact Factor 17.135
83. Pilgrim T, Franzone A, Stortecky S, Nietlispach F, Haynes AG, Tu-eller D, Toggweiler S, Muller O, Ferrari E, Noble S, Maisano F, Jeger R, Roffi M, GrŸnenfelder J, Huber C, Wenaweser P, Windecker S. Predicting Mortality After Transcatheter Aortic Valve Replacement: External Validation of the Transcatheter Valve Therapy Registry Mo-del. Circ Cardiovasc Interv. 2017. Impact Factor 7.198
50
90. Rigamonti F, Fahrni G, Maeder M, Cook S, Weilenmann D, Wenaweser P, Ršthlisberger C, Corti R, Rickli H, Kaiser C, Roffi M. Switzerland: coronary and structural heart interventions from 2010 to 2015. EuroIntervention. 2017. Impact Factor 5.165
91. Schoen T, Aeschbacher S, Leuppi JD, Miedinger D, WerthmŸller U, Estis J, Todd J, Risch M, Risch L, Conen D. Subclinical sleep apnoea and plasma levels of endothelin-1 among young and healthy adults. Open Heart 2017. Impact Factor
92. Shahinian JH, Mayer B, Tholen S, Brehm K, Biniossek ML, FŸllgraf H, Kiefer S, Heizmann U, Heilmann C, RŸter F, Grapow M, Reuthebuch OT, Eckstein F, Beyersdorf F, Schilling O, Siepe M. Pro-teomics highlights decrease of matricellular proteins in left ventri-cular assist device therapy. Eur J Cardiothorac Surg. 2017. Impact Factor 1.101
93. Spies F, KŸhne M, Reichlin T, Osswald S, Sticherling C, Knecht S. A quantitative comparison of the electrical and anatomical de-finition of the pulmonary vein ostium. Pacing Clin Electrophysiol. 2017. Impact Factor 1.486
94. Sticherling C, Arendacka B, Hastrup Svendsen J, Wijers S, Frie-de T, Stockinger J, Dommasch M, Merkely B, Willems R, Lubinski A, Scharfe M, Braunschweig F, Svetlosak M, ZŸrn CS, Huikuri H, Flevari P, Lund-Andersen C, Schaer BA, Tuinenburg AE, Bergau L, Schmidt G, Szeplaki G, Vanderberk B, Kowalczyk E, Eick C, Juntilla J, Conen D, Zabel M for the EU-CERT ICD investigators. Sex diffe-rences in outcomes of primary prevention ICD therapy: combined registry data from eleven European countries. Europace 2017. Impact Factor 4.530
95. Stauber A, Wey C, Greutmann M, Tobler D, Wustmann K, Wahl A, Valsangiacomo Buechel ER, Wilhelm M, Schwerzmann M. Left ventricular outflow tract obstruction and its impact on systolic ven-tricular function and exercise capacity in adults with a subaortic right ventricle. Int J Cardiol. 2017. Impact Factor 6.189
96. Staubli SM, Cerino G, Gonzalez De Torre I, Alonso M, Oertli D, Eckstein F, Glatz K, Rodríguez Cabello JC, Marsano A. Control of angiogenesis and host response by modulating the cell adhesion properties of an Elastin-Like Recombinamer-based hydrogel. Bio-materials. 2017;135:30-41. Impact factor 8.401
97. Thiele H, Akin I, Sandri M, Fuernau G, de Waha S, Meyer-Saraei R, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Savonitto S, Torremante P, Vrints C, Schneider S, Desch S, Zeymer U; CULPRIT-SHOCK Investigators (Jeger R Collaborator). PCI Stra-tegies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med. 2017. Impact Factor 72.406
98. Tobler D, Bouchardy J, Reto E, Heg D, MŸller C, Frenk A, Gabriel H, Schwitter J, Rutz T, Buechel RR, Willhelm M, Trachsel L, Freese M, Greutmann M, Schwerzmann M; SERVE trial. Effect of phos-phodiesterase-5 inhibition with Tadalafil on SystEmic Right VEntri-cular size and function - A multi-center, double-blind, randomized, placebo-controlled clinical trial - SERVE trial - Rational and design. Int J Cardiol. 2017. Impact Factor 6.189
99. Tobler D, Schwerzmann M, Bouchardy J, Engel R, Stambach D, Attenhofer Jost C, Wustmann K, Schwitz F, Rutz T, Gabriel H, Kuen HP, Auf der Maur C, Oxenius A, Seeliger T, Santos Lopes B, Bonassin F, Greutmann M. Swiss Adult Congenital Heart disease Registry (SACHER) - rationale, design and first results. Swiss Med Wkly. 2017. Impact Factor 1.654
100. Toma A, StŠhli BE, Gick M, Gebhard C, Kaufmann BA, Mas-hayekhi K, Ferenc M, Buettner HJ, Neumann FJ. Comparison of Be-nefit of Successful Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients With Versus Without Reduced (≤40%) Left Ventricular Ejection Fraction. Am J Cardiol. 2017. Impact Fac-tor 3.398
101. Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Puelacher C, Sabti Z, Rubini Gimenez M, Tschirky S, du Fay de Lavallaz J, Kozhuharov N, Sazgary L, Mueller D, Breidthardt T, Strebel I, Flores Widmer D, Shrestha S, Mir— ñ, Martín-S‡nchez FJ, Morawiec B, Parenica J, Geigy N, Keller DI, Rentsch K, von Eckard-stein A, Osswald S, Reichlin T, Mueller C. 0/1-Hour Triage Algorithm for Myocardial Infarction in Patients with Renal Dysfunction. Circu-lation 2017. Impact Factor 19.309
102. Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Rubini Gimenez M, Mir— ñ, Martín-S‡nchez FJ, Reichlin T, Mueller C. Effect of the FDA Regulatory Approach on the 0/1-h Al-gorithm for Rapid Diagnosis of MI. Journal of the American College of Cardiology 2017. Impact Factor 19.896
51
Publikationen
10 Publikationen
110. Wildi K, Cullen L, Twerenbold R, Greenslade JH, Parsonage W, Boeddinghaus J, Nestelberger T, Sabti Z, Rubini-Gim�nez M, Puela-cher C, Cupa J, Schumacher L, Badertscher P, Grimm K, Kozhuha-rov N, Stelzig C, Freese M, Rentsch K, Lohrmann J, Kloos W, Buser A, Reichlin T, Pickering JW, Than M, Mueller C. Direct Comparison of two Rule-out Strategies for Acute Myocardial Infarction: 2h-Ac-celerated Diagnostic Protocol versus 2h-Algorithm. Clin Chemistry 2017. Impact Factor 8.008
111. Yang H, Bouma BJ, Mulder BJM. Is Initiating NOACs for Atrial Arrhythmias Safe in Adults with Congenital Heart Disease? Cardio-vasc Drugs Ther. 2017. Impact Factor 2.820
112. Zbinden R, von Felten S, Wein B, Tueller D, Kurz DJ, Reho I, Galatius S, Alber H, Conen D, Pfisterer M, Kaiser C, Eberli FR. Im-pact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents - a clinical and health-economic evaluation. Cardiovasc Ther. 2017. Im-pact Factor 2.478
113. Zellweger MJ, Haaf P, Maraun M, Osterhues HH, Keller U, MŸller-Brand J, Jeger R, Pfister O, Brinkert M, Burkard T, Pfisterer M; BARDOT Investigators. Predictors and prognostic impact of si-lent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus. Int J Cardiol. 2017. Impact Factor 6.189
114. Zimny M, Blum S, Ammann P, Erne P, Moschovitis G, Di Valen-tino M, Shah D, SchlŠpfer J, Vogt C, Tabord A, KŸhne M, Sticherling C, Osswald S, Conen D. Uptake of non-vitamin K antagonist oral anti coagulants in patients with atrial fibrillation - a prospective co-hort study. Swiss Med Wkly 2017. Impact Factor 1.654
Reviews
1. Celikyurt I, Meier CR, KŸhne M, Schaer B. Safety and interactions of direct oral anticoagulants with antiarrhythmic drugs. Drug Saf 2017. Impact Factor 3.439
2. Garg P, Morris P, Fazlanie AL, Vijayan S, Dancso B, Dastidar AG, Plein S, Mueller C, Haaf P. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Intern Emerg Med. 2017. Epub 2017. Review. Impact Factor 2.340
103. Van der Linden N, Cornelis T, Kimenai DM, Klinkenberg LJJ, Hilderink JM, LŸck S, Litjens EJR, Peeters FECM, Streng AS, Breidthardt T, van Loon LJC, Bekers O, Kooman JP, Westermark PO, Mueller C, Meex SJR.The Origin of Cardiac Troponin T Elevations in Chronic Kidney Disease. Circulation 2017. Impact Factor 19.309
104. Vischer AS, Winterhalder C, Leonardi L, Maseli A, Eckstein J, Burkard T. Is office blood pressure measurement reliable for in-dividual decision making? � Rsultes of the iPARR trial. Journal of Hypertension 2017. Impact Factor 4.085
105. Vischer AS and Burkard T. Principles of Blood Pressure Measu-rement - Current Techniques, Office vs Ambulatory Blood Pressure Measurement. Adv Exp Med Biol. 2017. Impact Factor 1.881
106. Wagener M, AbŠcherli R, Honegger U, Schaerli N, Pr�tre G, Twerenbold R, Puelacher C, Sunier G, Reddiess P, Rubini Gimenez M, Wildi K, Boeddinghaus J, Nestelberger T, Badertscher P, Sab-ti Z, Schmid R, Leber R, Widmer DF, Shrestha S, Strebel I, Wild D, Osswald S, Zellweger M, Mueller C, Reichlin T. Diagnostic and prognostic value of lead aVR during exercise testing in patients su-spected of having myocardial ischemia. Am J Cardiol 2017. Impact Factor 3.398
107. Walter JE, Honegger U, Puelacher C, Mueller D, Wagener M, Schaerli N, Strebel I, Twerenbold R, Boeddinghaus J, Nestelberger T, Sazgary L, Marbot S, de Lavallaz JDF, Kaiser C, Osswald S, Wild D, Rentsch K, Zellweger M, Reichlin T, Mueller C. Prospective Validati-on of a Biomarker-Based Rule Out Strategy for Functionally Relevant Coronary Artery Disease. Clin Chem. 2017. Impact Factor 8.008
108. Wein B, Coslovsky M, Jabbari R, Galatius S, Pfisterer M, Kaiser C. Prasugrel vs. clopidogrel in contemporary Western European pa-tients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts. Int J Cardiol. 2017. Impact Factor 6.189
109. Wienbergen H, Pfister O, Hochadel M, Michel S, Bruder O, Remppis BA, Maeder MT, Strasser R, von Scheidt W, Pauschinger M, Senges J, Hambrecht R; RAID-HF (Registry Analysis of Iron De-ficiency–Heart Failure) REGISTRY Study Group (*joint first author-ship). Usefulness of iron deficiency correction in management of patients with heart failure (from the Registry Analysis of Iron Devi-ciency-Heart Failure (RAID-HF) Registry. Am J Cardiol. 2016 Impact Factor 3.398
52
3. Gorenek B, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV, Healey JS, Israel CW, Kudaiberdieva G, Levin L�, Lip GYH, Martin D, Okumura K, Svendsen JH, Tse HF, Botto GL; Document Review-ers: Sticherling C (Reviewer Coordinator), Linde C, Kutyifa V, Bernat R, Scherr D, Lau CP, Iturralde P, P Morin D, Savelieva I. Device-detected subclinical atrial tachyarrhythmis: definition, implications and management � an European Heart Rhythm Association (EHRA) consensus document. Europace 2017. Impact Factor 4.210
4. Harjola VP, Mullens W, Banaszewski M, Bauersachs J, Brunner-La Rocca HP, Chioncel O, Collins SP, Doehner W, Filippatos GS, Flammer AJ, Fuhrmann V, Lainscak M, Lassus J, Legrand M, Masip J, Mueller C, Papp Z, Parissis J, Platz E, Rudiger A, Ruschitzka F, SchŠfer A, Seferovic PM, Skouri H, Yilmaz MB, Mebazaa A. Organ dysfunction, injury and failure in acute heart failure: from patho-physiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2017. Impact Factor 6.968
5. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsk� P; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myo-cardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2017 [Epub ahead of print] Impact Factor 19.651
6. Lip GYH, Collet JP, Caterina R, Fauchier L, Lane DA, Larsen TB, Marin F, Morais J, Narasimhan C, Olshansky B, Pierard L, Potpara T, Sarrafzadegan N, Sliwa K, Varela G, Vilahur G, Weiss T, Boriani G, Rocca B, Gorenek B, Savelieva I, Sticherling C, Kudaiberdieva G, Chao TF, Violi F, Nair M, Zimerman L, Piccini J, Storey R, Halvorsen S, Gorog D, Rubboli A, Chin A, Scott-Millar R. Antithrombotic thera-py in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Associati-on (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Socie-dad Latinoamericana de Estimulaci—n Cardíaca y Electrofisiolog’a (SOLEACE) Europace 2017. Impact Factor 4.530
7. Mair J, Lindahl B, Giannitsis E, Huber K, Thygesen K, Plebani M, Mšckel M, MŸller C, Jaffe AS; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Association. Will sa-cubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care? Eur Heart J Acute Cardiovasc Care. 2017.
8. Mair J, Lindahl B, MŸller C, Giannitsis E, Huber K, Mšckel M, Plebani M, Thygesen K, Jaffe AS; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Associ-ation. What to do when you question cardiac troponin values? Eur Heart J Acute Cardiovasc Care. 2017.
9. Mair J, Lindahl B, MŸller C, Giannitsis E, Huber K, Mšckel M, Plebani M, Thygesen K, Jaffe AS. What to do when you question cardiac troponin values. Eur Heart J Acute Cardiovasc Care. 2017
10. Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J, Varman N, Glotz de Lima G, Kalman J, Claes N, Lobban T, Lane D, Lip GYH, Boriani G; Collaborators: Fauchier L, Jung W, Savelieva I, Freedman B, Chen SA, Isa R, Turakhia M, Sapp JL, Lip G, Gorenek B, Sticherling C, Fachier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Lundqvist CB, Savelieva I. Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulaci—n Cardíaca y Electrofisiología (SOLAECE). Europace. Impact Factor 4.521
11. Miro O, Peacock FW, Christ M, Cowie M, Cullen L, Maisel AS, Masip J, Miro O, McMurray J, Peacock FW, Price S, DiSomma S, Bueno H, Zeymer U, Mebazaa A, Mueller C. European Society of Car-diology - Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency de-partment. European Heart Journal: Acute Cardiovascular Care 2017
12. Mont L, Pelliccia A, Sharma S, Biffi A, Borjesson M, Brugada Terradel-las J, Carr� F, Guasch E, Heidbuchel H, La Gerche A, Lampert R, McKenna W, Papadakis M, Priori SG, Scanavacca M, Thompson P, Sticherling C, Viskin S, Wilson M, Corrado D; Reviewers., Lip GY, Gorenek B, Blomstršm Lundqvist C, Merkely B, Hindricks G, Hern‡ndez-Madrid A, Lane D, Boria-ni G, Narasimhan C, Marquez MF, Haines D, Mackall J, Manuel Marques-Vidal P, Corra U, Halle M, Tiberi M, Niebauer J, Piepoli M. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden cardi-ac death: Position paper from the EHRA and the EAPCR, branches of the ESC. Endorsed by APHRS, HRS and SOLACE. Eur J Prev Cardiol 2017. Impact Factor 3.606. Europace 2017. Impact Factor 4.530
53
Publikationen
10 Publikationen
21. Sarkozy A, De Potter T, Heidbuchel H, Ernst S, Kosiuk J, Vano E, Picano E, Arbelo E, Tedrow U, Y H Lip G, Bajers F, Blomstršm Lundqvist C, Mandrola J, Lane DA, Dagres N, Chung MK, Wunderle KA, Lip G, Gorenek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin F, Boriani G, Lane D, Lundqvist CB, Savelieva I. Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with repro-ductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart rhythm Society (HRS). Europace 2017. Impact Factor 4.530
22. StŠmpfli SF, Erhart L, Hagenbuch N, StŠhli BE, Gruner C, Greut-mann M, Niemann M, Kaufmann BA, Jenni R, Held L, Tanner FC. Prognostic power of NT-proBNP in left ventricular non-compaction cardiomyopathy. Int J Cardiol. 2017. Impact Factor 6.189
23. Timmermanns Y, Meine M, Zitron E, Widdershoven J, Kimman G, Prevot S, Rauwolf T, Anselme F, Szendey I, Roldan J, Mabo P, Schaer B, Denollet J, Versteeg H. The patient perspective on remote monitoring of patients with an implantable cardioverter defibrillator: Narrative review and future directions. Pacing Clin Electrophysiol 2017. Impact Factor 1.486
24. Twerenbold R, Jasper Boeddinghaus, Thomas Nestelberger, Karin Wildi, Maria Rubini Gimenez, Patrick Badertscher, Mueller C. Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol. 2017. Impact Factor 19.896
25. Zellweger MJ. The complex principle of cause and effect. J Nucl Cardiol. 2017. Impact Factor 3.930
Editorials
1. Cleland JG, Mueller C. What can we learn from SOCRATES: more questions than answers? Eur Heart J. 2017. Impact Factor 19.651
2. Haaf P, Buser PT. Map to the future of cardiac magnetic reso-nance in myocarditis. Eur Heart J Cardiovasc Imaging. 2017. Im-pact Factor 5.990
3. Haaf P. Lowering the bar of high-sensitivity cardiac troponin: more than limbo dancing? J Lab Precis Med 2017.
4. KŸhne M, Knecht S, Sticherling C. Editorial: Cryoballoon ablation: the pure and simple truth about the left common ostium? Heart Rhythm 2017. Impact Factor 4.866
13. Mšckel M, Giannitsis E, Mueller C, Huber K, Jaffe AS, Mair J, Plebani M, Thygesen K, Lindahl B; Biomarker Study Group of the European Society of Cardiology Acute Cardiovascular Care Associ-ation. Rule-in of acute myocardial infarction: Focus on troponin. Eur Heart J Acute Cardiovasc Care. 2017
14. Mueller C, Giannitsis E, Mšckel M, Huber K, Mair J, Plebani M, Thygesen K, Jaffe AS, Lindahl B; Biomarker Study Group of the ESC Acute Cardiovascular Care Association. Rapid rule out of acute myocardial infarction: novel biomarker-based strategies. Eur Heart J Acute Cardiovasc Care. 2017
15. MŸller C, Mšckel M, Giannitsis E, Huber K, Plebani M, Thygesen K, Jaffe AS, Mair J, Lindahl B,; Biomarker Study Group of the Euro-pean Society of Cardiology Acute Cardiovascular Care Association. Use of copeptin for rapid rule-out of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2017
16. MŸller C, Stefan Windecker, Marco Roffi fŸr die ESC 2015 NS-TE-ACS Task Force. Akutes Koronarsyndrom ohne ST-Hebungen: ESC-Richtlinien 2015. J CARDIOVASC MED 2017. Impact Factor 1.613
17. Price S, Platz E, Cullen L, Tavazzi G, Christ M, Cowie M, Maisel A, Masip J, Miro O, McMurray J, Peacock WF, Martin-Sanchez FJ, Di Somma S, Bueno H, Zeymer U, Mueller C. The use of echo-cardio-graphy and lung ultrasound in the assessment and manage-ment of patients with acute heart failure. Nature Reviews Cardiol 2017. Impact Factor 14.299
18. Reek S, Burri H, Roberts PR, Perings C, Epstein AE, Klein HU, Lip G, Goronek B, Sticherling C, Fauchier L, Goette A, Jung W, Vos MA, Brignole M, Elsner C, Dan GA, Marin f, Boriani G, Lane D, Lundqvist CB, Savelieva I. The wearable cardioverter-defibrillator: current technology and evolving indications. Europace 2017. Im-pact Factor 4.530
19. Roos-Hesselink JW, Tobler D, Warnes C. The 2017 Seventh World Congress of Pediatric Cardiology & Cardiac Surgery: week in review - adults with CHD. Cardiol Young. 2017. Impact Fac-tor 0.905
20. Sabti Z, Jeger R. VollstŠndig resorbierbare Stents � eine neue �ra in der Behandlung der koronaren Herzkrankheit? Praxis (Bern 1994). 2017. Impact Factor 0.06
54
5. Mueller C. Clinical utility of biomarkers in heart failure. Eur J Heart Fail. 2017. [Epub ahead of print]. Impact Factor 6.968
6. Sticherling C, KŸhne M. Editorial: Pulmonary vein isolation wi-thout assessing pulmonary vein potentials � not there yet. Heart Rhythm 2017. Impact Factor 4.866
Letters to the editor
1. Badertscher P, du Fay de Lavallaz J, Mueller C. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med 2017. Impact factor 72.406
2. Badertscher P, Kuehne M, Schaer B, Sticherling C, Osswald S, Reichlin T. Electrical storm during induced hypothermia in a pati-ent with early repolarization. BMC Cardiovasc Disord 2017. Impact Factor 1.832
3. Badertscher P, Nestelberger T, Boeddinghaus J, Twerenbold R, Wildi K, Rubini Gimenez M, Mueller C. High sensitive cardiac tro-ponin T: Testing the test. Int J Cardiol 2017. Impact Factor 6.189
4. Flores D, Sabti Z, Kozhuharov N, Mueller C. Sacubitril/valsartan in PARADIGM-HF. Lancet Diabetes Endocrinol. 2017. Impact Factor 19.742
5. KŸhne M. Vorhofflimmern 2017 � die neuen ESC-Guidelines hel-fen, aber es bleiben offene Fragen. Praxis (Bern 1994) 2017. Impact Factor 0.06
6. Mueller C, Roffi M, on behalf of the ESC NSTE-ACS Guidelines. Assessment of the European Society of Cardiology 0 hour/1hour algorithm to rule-out and rule-in acute myocardial infarction. Circu-lation 2017. Impact factor 19.309
Case reports
1. Knecht S, Spies F, Altmann D, Reichlin T, Sticherling C, KŸhne M. Electroanatomic mapping of atrial tachycardia � manual vs automa-ted annotation. HeartRhythm Case Rep. 2017. Impact Factor 4.866
2. Spies F, Knecht S, Reichlin T, KŸhne M, Sticherling C. Remotely navigated ablation of RVOT tachycardia. Cardiovasc Med 2017. Im-pact Factor 1.613
3. Zutter A, Hauri K, Evers KS, Uhde S, Fassl J, Reuthebuch OT, Berset A, KŸhne M, Donner BC. "Chaotic Arrhythmia" During Suc-cessful Resuscitation After Ingestion of Yew (Taxus baccata) Need-les. Pediatr Emerg Care. [Epub ahead of print]. Impact Factor 1.034
Books / Book chapters
1. Greutmann M, Tobler D (2017) Supportive and Palliative Care for End-Stage adult congenital heart disease in: Gatzoulis, M; Webb, G; Daubeney, P. (eds) Diagnosis and Management of Congenital Heart Disease, 3rd edition. Elsevier Verlag ISBN 9780702069291, © 2017
2. Greutmann M., Tobler D. (2017) Cyanotic lesions in: In: Roos-Hesselink J., Johnson M. (eds) Pregnancy and Congenital Heart Di-sease. Congenital Heart Disease in Adolescents and Adults. Sprin-ger, Cham. https://doi.org/10.1007/978-3-319-38913-4_16
3. Mannhardt I, Marsano A, Teuschl A. Perfusion Bioreactors for Prevascularization Strategies in Cardiac Tissue Engineering in Va-scularization for Tissue Engineering and Regenerative Medicine, Springer International Publishing, 2017 pp 1-14. doi:10.1007/978-3-319-21056-8_14-1.
4. Mueller C. Other Biomarkers and the Evaluation of Patients With Suspected Myocardial Acute Myocardial Infarction. in Morrow: Myocrdial Infarction A Companion to Braunwald's Heart Disease, 2017; 1e. Chapter 8.
5. Oechslin E, Greutmann M, Tobler D, Colman J (2017) Selec-ted Terms Used in Adult Congenital Heart Disease in: Gatzou-lis, M; Webb, G; Daubeney, P. (eds) Diagnosis and Management of Congenital Heart Disease, 3rd edition. Elsevier Verlag ISBN 9780702069291, © 2017
6. Tobler D., Greutmann M. (2017) Transpostion of the great arteries. In: Roos-Hesselink J., Johnson M. (eds) Pregnancy and Congenital Heart Disease. Congenital Heart Disease in Adolescents and Adults. Springer, Cham. https://doi.org/10.1007/978-3-319-38913-4_8
7. Tobler D., Jimenez-Juan L., Crean A.M., Wald R.M. (2017) Tri-cuspid Valve Abnormalities in: Medical Radiology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2017_108
55
Auszeichnungen
Auszeichnungen / Befšrderungen
PD Dr. Tobias Reichlin: Ruf als Extraordinarius fŸr Elektro- physiologie, Inselspital Bern
Prof. Christian Sticherling: Stv. Chefarzt Kardiologie
Dissertationen
Dissertationen bei Prof. David Conen
Dr. Fischer Andreas Charles: Plasma levels of endothelin-1 and renal function among young and healthy adults
Dr. Kreuzmann Rahel Ursula: Determinants of Left Atrial Volu-me in Patients with Atrial Fibrillation
Dr. Maseli Anna: Healthy Lifestyle and Blood Pressure Varia-bility in Young Adults
Dr. Muff Christoph Martin: Prospective Assessment of Sex-Related Differences in Symptom Status and Health Perception Among Patients With Atrial Fibrillation
Dr. von Rotz Mirco Lukas: Risk factors for premature ventricu-lar contractions in young and healthy adults
Dr. Zimny Matylda Magdalena: Uptake of non-vitamin K anta-gonist oral anti-coagulants in patients with atrial fibrillation � a prospective cohort study
Dissertationen bei PD Dr. Jens Fassl
Dr. Mayer Tanja Melanie: Urine Biomarkers of Tubular Renal Cell Damage for the Prediction of Acute Kidney Injury After Cardiac Surgery - A Pilot Study
11 Auszeichnungen
Dissertationen bei PD Dr. Mischa KŸhne
Dr. Fabian Burch: First clinical experience of a dedicated irri-gated-tip radiofrequency ablation catheter for the ablation of cavo
Dissertationen bei Prof. Christian MŸller
Dr. Barata Sara: Diagnostic and Prognostic Value of Cystatin C in Acute Heart Failure
Dr. Dang Minh Quy: Risk stratification by preoperative high-sensitivity troponin and NT-BNP in patients undergoing non-cardiac
Dr. Hillinger Petra: Gender-specific uncertainties in the diagno-sis of acute coronary syndrome
Dr. Hodel Karin: Diagnostic Accuracy of Cardiovascular Risk Factors for an Acute Coronary Syndrome
Dr. Lšffel Sarah: Direct comparison of cardiac myosin-binding protein C to cardiac troponins for the early diagnosis of acute myocardial infarction
Dr. Pfister Tabea Lon Ming: The Acute Cardiorenal Syndrome versus Acute Kidney Injury in Non-Cardiac Dyspnea: Long-term Mortality and Progression of Renal Disease
Dr. Radosavac Milos: New quality indicator for treatment of acute myocardial infarction
Dr. Sedlmayer Raphael Paul: Near-Linearity of Release of Car-diac Troponin in Early Acute Myocardial Infarction
Dr. Wagener Max: Diagnostic and Prognostic Value of Lead aVR During Exercise Testing in Patients Suspected of Having Myocardial Ischemia
56
Dissertationen bei PD Dr. Otmar Pfister
Dr. Fischer Marc Lorenz: Congestive heart failure with conco-mitant tachyarrhythmia: Predictors for tachycardiomyopathy
Dissertationen bei PD Dr. Anna Marsano
Dr. Mytsyk Miroslava: Paracrine potential of adipose tissue-derived stromal vascular fraction cells to recover hypoxia-induced loss of cardiomyocyte function
Forschungspreis
Dr. Federico Moccetti: Young Investigator’s Award American Society of Echocardiography 2017
57
Kontakt
Kardiologie Basel
ChefarztProf. Dr. med. Stefan Osswald
AnschriftKardiologie BaselUniversitŠtsspital BaselPetersgraben 4CH - 4031 Baselunispital-basel.ch/kardiologie
Allgemeine AuskŸnfteTel +41 61 265 44 44, Fax +41 61 265 45 98Email: kardiologie@usb.ch
Anmeldung ambulante und stationŠre Patienten Tel. +41 61 265 44 45, Fax +41 61 265 55 75Email: anmeldung.kardiologie@usb.ch
Anmeldung kardiale RehabilitationTel. +41 61 328 65 27, Fax +41 61 265 55 03Email: karamba@usb.ch
Dienstarzt KardiologieTel. + 41 61 556 58 00
12 Kontakt
Herzchirurgie Basel
ChefarztProf. Dr. med. Friedrich Eckstein
AnschriftHerzchirurgie BaselUniversitŠtsspital BaselSpitalstrasse 21CH - 4031 Baselunispital-basel.ch/herzchirurgie
ChefarztsekretariatJolanda Giess Tel. +41 61 265 71 45, Fax +41 61 265 73 24Email: jolanda.giess@usb.ch
AnmeldungStationŠre Patienten Tel. + 41 61 265 71 45Ambulante Patienten Tel. + 41 61 265 71 45Aortensprechstunde Tel. + 41 61 265 71 46
Dienstarzt HerzchirurgieTel. + 41 61 556 58 58
58
Impressum
Herausgeber: Herzzentrum Basel; Redaktion: Christoph Kaiser (Leitung), Stefan Osswald, Friedrich Eckstein, Christian MŸller, Florian RŸter, Markus Riesterer, Arton Jusaj, Ursula Vogt
Fotos: Patrick Sayer, Markus Riesterer, Fabian Fiechter, Foto & Print Center USB, Christian Jaeggi
Konzeption: Markus Riesterer; Gestaltung: strawberry design; Druck: strawberry events; Auflage: 1'500 Ex.
Diese Publikation, einschliesslich all ihrer Texte, ist urheberrechtlich geschŸtzt. Jede Verwendung ausserhalb der engen Grenzen des Urheberrechts ist ohne Zustimmung des Herzzentrums und der beteiligten Institutionen unzulŠssig und strafbar. Dies gilt insbesondere fŸr VervielfŠltigungen, †bersetzungen, Mikroverfilmungen, sowie fŸr die Einspeicherung und Verarbeitung in elektronischen Systemen.
unispital-basel.ch/kardiologie I unispital-basel.ch/herzchirurgie
Recommended